Horizon Technology Finance (HRZN) 10-Q 30 Apr 24 2024 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2024	Apr. 30, 2024
Document Information [Line Items]
Entity Central Index Key	0001487428
Entity Registrant Name	Horizon Technology Finance Corp
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	814-00802
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-2114934
Entity Address, Address Line One	312 Farmington Avenue
Entity Address, City or Town	Farmington
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06032
City Area Code	860
Local Phone Number	676‑8654
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		35,020,774
The 6.25% Notes due 2027 [Member]
Document Information [Line Items]
Title of 12(b) Security	6.25% Notes due 2027
Trading Symbol	HTFC
Security Exchange Name	NYSE
The 4.875% Notes due 2026 [Member]
Document Information [Line Items]
Title of 12(b) Security	4.875% Notes due 2026
Trading Symbol	HTFB
Security Exchange Name	NYSE
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	HRZN
Security Exchange Name	NASDAQ

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets
Investments at fair value	$ 711,116	$ 709,085
Cash	46,921	46,630
Investments in money market funds	21,879	26,450
Restricted investments in money market funds	2,533	2,642
Interest receivable	16,579	13,926
Other assets	3,260	3,623
Total assets	802,288	802,356
Liabilities
Borrowings (Note 7)	452,490	462,235
Distributions payable	13,099	11,011
Base management fee payable (Note 3)	1,058	1,052
Incentive fee payable (Note 3)	295	0
Other accrued expenses	3,225	4,077
Total liabilities	470,167	478,375
Net assets
Preferred stock, par value $0.001 per share, 1,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2024 and December 31, 2023	0	0
Common stock, par value $0.001 per share, 100,000,000 shares authorized, 34,637,343 and 33,534,854 shares issued and 34,469,878 and 33,367,389 shares outstanding as of March 31, 2024 and December 31, 2023, respectively	37	36
Paid-in capital in excess of par	463,539	450,949
Distributable loss	(131,455)	(127,004)
Total net assets	332,121	323,981
Total liabilities and net assets	$ 802,288	$ 802,356
Net asset value per common share (in dollars per share)	$ 9.64	$ 9.71
Investment, Unaffiliated Issuer [Member]
Assets
Investments at fair value	$ 684,895	$ 693,730
Investment, Affiliated Issuer, Noncontrolled [Member]
Assets
Investments at fair value	12,577	1,132
Investment, Affiliated Issuer, Controlled [Member]
Assets
Investments at fair value	$ 13,644	$ 14,223

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Investments at cost	$ 765,173	$ 759,182
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares oustanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	34,637,343	33,534,854
Common stock, shares outstanding (in shares)	34,469,878	33,367,389
Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 721,456	$ 716,077
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost	28,689	28,677
Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	$ 15,028	$ 14,428

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Investment income
Payment-in-kind interest income	$ 1,382	$ 1,204
Total investment income	26,129	28,037
Expenses
Interest expense	8,161	7,120
Base management fee (Note 3)	3,162	3,201
Performance based incentive fee (Note 3)	295	2,978
Administrative fee (Note 3)	433	440
Professional fees	665	658
General and administrative	429	445
Total expenses	13,145	14,842
Net investment income before excise tax	12,984	13,195
Provision for excise tax	379	184
Net investment income	12,605	13,011
Net realized and unrealized loss
Net realized gain (loss) on investments	8	(168)
Net unrealized appreciation (depreciation) on investments	(3,960)	(7,537)
Net realized and unrealized loss	(3,952)	(7,705)
Net increase in net assets resulting from operations	$ 8,653	$ 5,306
Net investment income per common share (in dollars per share)	$ 0.38	$ 0.46
Net increase in net assets resulting from operations per common share (in dollars per share)	0.26	0.19
Distributions declared per share (in dollars per share)	$ 0.38	$ 0.33
Weighted average shares outstanding (in shares)	33,579,743	28,227,100
Investment, Unaffiliated Issuer [Member]
Investment income
Interest income	$ 24,468	$ 26,195
Fee income	268	638
Payment-in-kind interest income	1,216	1,204
Net realized and unrealized loss
Net realized gain (loss) on investments	11	(168)
Net unrealized appreciation (depreciation) on investments	(14,214)	(8,383)
Investment, Affiliated Issuer, Controlled [Member]
Investment income
Interest income	11	0
Payment-in-kind interest income	166	0
Net realized and unrealized loss
Net realized gain (loss) on investments	0
Net unrealized appreciation (depreciation) on investments	(1,179)	0
Investment, Affiliated Issuer, Noncontrolled [Member]
Investment income
Interest income	0	0
Net realized and unrealized loss
Net realized gain (loss) on investments	(3)	0
Net unrealized appreciation (depreciation) on investments	$ 11,433	$ 846

Consolidated Statements of Chan

Consolidated Statements of Changes in Net Assets (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Common Stock Outstanding [Member]
Balance (in shares)	33,367,389	27,753,373
Issuance of common stock, net of offering costs (in shares)	1,053,796	605,848
Issuance of common stock under dividend reinvestment plan (in shares)	48,693	18,136
Balance (in shares)	34,469,878	28,377,357
Common Stock [Member]
Balance	$ 36	$ 29
Issuance of common stock, net of offering costs	1	1
Net investment income, net of excise tax	0	0
Net realized gain (loss) on investments	0	0
Net unrealized appreciation (depreciation) on investments	0	0
Issuance of common stock under dividend reinvestment plan	0	0
Distributions declared	0	0
Balance	37	30
Additional Paid-in Capital [Member]
Balance	450,949	385,921
Issuance of common stock, net of offering costs	11,971	7,173
Net investment income, net of excise tax	0	0
Net realized gain (loss) on investments	0	0
Net unrealized appreciation (depreciation) on investments	0	0
Issuance of common stock under dividend reinvestment plan	619	218
Distributions declared	0	0
Balance	463,539	393,312
Retained Earnings [Member]
Balance	(127,004)	(67,502)
Issuance of common stock, net of offering costs	0	0
Net investment income, net of excise tax	12,605	13,011
Net realized gain (loss) on investments	8	(168)
Net unrealized appreciation (depreciation) on investments	(3,960)	(7,537)
Issuance of common stock under dividend reinvestment plan	0	0
Distributions declared	(13,104)	(9,463)
Balance	(131,455)	(71,659)
Balance	323,981	318,448
Issuance of common stock, net of offering costs	11,972	7,174
Net investment income, net of excise tax	12,605	13,011
Net realized gain (loss) on investments	8	(168)
Net unrealized appreciation (depreciation) on investments	(3,960)	(7,537)
Issuance of common stock under dividend reinvestment plan	619	218
Distributions declared	(13,104)	(9,463)
Balance	$ 332,121	$ 321,683

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net increase in net assets resulting from operations	$ 8,653	$ 5,306
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by operating activities:
Amortization of debt issuance costs	393	478
Net realized (gain) loss on investments	(8)	168
Net unrealized depreciation on investments	3,960	7,537
Purchase of investments	(23,319)	(47,008)
Principal payments received on investments	19,643	39,756
Payment-in-kind interest on investments	(1,382)	(1,204)
Proceeds from sale of investments	41	6,520
Changes in assets and liabilities:
(Increase) decrease in interest receivable	(1,695)	840
Increase in end-of-term payments	(958)	(1,017)
Decrease in unearned income	(952)	(1,148)
Decrease in other assets	216	98
(Decrease) increase in other accrued expenses	(852)	824
Increase (decrease) in base management fee payable	6	(6)
Increase in incentive fee payable	295	1,586
Net cash provided by operating activities	4,041	12,730
Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering costs	11,972	7,174
Advances on Credit Facilities	0	10,000
Repayment of Credit Facilities	(10,000)	0
Debt issuance costs	(5)	(19)
Distributions paid	(10,397)	(9,039)
Net cash (used in) provided by financing activities	(8,430)	3,333
Net (decrease) increase in cash, cash equivalents and restricted cash	(4,389)	16,063
Cash, cash equivalents and restricted cash:
Beginning of period	75,722	30,466
End of period	71,333	46,529
Supplemental disclosure of cash flow information:
Cash paid for interest	7,565	6,623
Supplemental non-cash investing and financing activities:
Refinanced debt investment balances	11,250	0
Warrant investments received and recorded as unearned income	128	141
Distributions payable	13,099	9,365
End-of-term payments receivable	12,774	10,799
Non-cash income	4,103	3,944
Cash	46,921	19,844
Investments in money market funds	21,879	23,698
Restricted investments in money market funds	2,533	2,987
Total cash, cash equivalents and restricted cash	71,333	46,529
Asset-backed Notes 2019 [Member]
Cash flows from financing activities:
Repayment of notes	$ 0	$ (4,783)

Consolidated Schedule of Invest

Consolidated Schedule of Investments (Unaudited)	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Schedule of Investments [Text Block]	March 31, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Investments — 206.2 Non-Affiliate Debt Investments — 196.6 Non-Affiliate Debt Investments — Life Science — 76.8 Castle Creek Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 $ 5,000 $ 4,982 $ 4,982 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,982 4,982 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,989 2,989 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,982 4,982 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,982 4,982 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,989 2,989 Emalex Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % June 1, 2024 565 564 564 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % June 1, 2024 565 564 564 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % November 1, 2025 5,000 4,957 4,957 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % May 1, 2026 5,000 4,958 4,958 Greenlight Biosciences, Inc. (2)(12) Biotechnology Term Loan 14.25 % Prime 5.75 % 9.00 % - 3.00 % July 1, 2025 2,500 2,429 2,429 Term Loan 14.25 % Prime 5.75 % 9.00 % - 3.00 % July 1, 2025 1,250 1,215 1,215 KSQ Therapeutics, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.50 % May 1, 2027 6,250 6,204 6,204 Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.50 % May 1, 2027 6,250 6,204 6,204 Native Microbials, Inc (2)(12) Biotechnology Term Loan 13.75 % Prime 5.25 % 8.50 % - 5.00 % November 1, 2026 3,750 3,725 3,725 Term Loan 13.75 % Prime 5.25 % 8.50 % - 5.00 % November 1, 2026 2,500 2,484 2,484 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 10,000 9,924 9,924 Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 3,750 3,722 3,722 Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 3,750 3,722 3,722 Provivi, Inc. (2)(12) Biotechnology Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 4,667 4,603 4,327 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 4,667 4,603 4,327 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 2,333 2,295 2,158 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 2,333 2,295 2,158 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 2,333 2,293 2,156 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 2,333 2,293 2,156 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % October 1, 2025 3,643 3,594 3,594 Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % October 1, 2025 1,821 1,797 1,797 Tallac Therapeutics, Inc. (2)(12) Biotechnology Term Loan 12.75 % Prime 4.25 % 12.25 % - 4.00 % August 1, 2027 2,500 2,232 2,232 Term Loan 12.75 % Prime 4.25 % 12.25 % - 4.00 % August 1, 2027 2,500 2,462 2,462 Aerobiotix, LLC (2)(12) Medical Device Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 2,500 2,471 2,339 Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 2,500 2,471 2,339 Term Loan 9.00 % Fixed - - - 18.00 % June 30, 2024 200 200 189 Candesant Biomedical, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 5,000 4,764 4,764 Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 2,500 2,457 2,457 Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 2,500 2,457 2,457 Ceribell, Inc. (2)(12) Medical Device Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 5,000 4,811 4,811 Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 5,000 4,932 4,932 Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 4,000 3,946 3,946 Cognoa, Inc. (2)(12) Medical Device Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % August 1, 2026 4,375 4,332 4,332 Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % August 1, 2026 2,188 2,166 2,166 Conventus Orthopaedics, Inc. (2)(12) Medical Device Term Loan 13.32 % Prime 4.82 % 9.25 % - 10.36 % July 1, 2025 3,911 3,864 3,864 Term Loan 13.32 % Prime 4.82 % 9.25 % - 10.36 % July 1, 2025 3,911 3,864 3,864 CSA Medical, Inc. (2)(12) Medical Device Term Loan 13.59 % Prime 5.09 % 10.00 % - 5.00 % January 1, 2024 391 391 391 Term Loan 13.59 % Prime 5.09 % 10.00 % - 5.00 % March 1, 2024 533 533 533 MicroTransponder, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % - 3.50 % January 1, 2029 3,750 3,691 3,691 Term Loan 12.25 % Prime 3.75 % 12.25 % - 3.50 % January 1, 2029 3,750 3,691 3,691 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) March 31, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Scientia Vascular, Inc. (2)(12) Medical Device Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.00 % January 1, 2027 3,750 3,726 3,726 Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.00 % January 1, 2027 3,750 3,725 3,725 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % January 1, 2027 5,000 4,949 4,949 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % January 1, 2027 5,000 4,909 4,909 Sonex Health, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 2,500 2,475 2,475 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 2,500 2,475 2,475 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 5,000 4,950 4,950 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 5,000 4,950 4,950 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,706 3,706 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,706 3,706 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,706 3,706 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,706 3,706 Spineology, Inc. (2)(12) Medical Device Term Loan 15.50 % Prime 7.00 % 10.25 % - 1.00 % October 1, 2025 5,000 4,981 4,981 Term Loan 15.50 % Prime 7.00 % 10.25 % - 1.00 % April 1, 2026 2,500 2,491 2,491 Swift Health Systems Inc. (2)(12) Medical Device Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,470 3,470 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,470 3,470 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,459 3,459 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,459 3,459 Vero Biotech, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 15,000 14,690 14,690 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 10,000 9,793 9,793 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 5,000 4,897 4,897 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 2,500 2,449 2,449 Total Non-Affiliate Debt Investments — Life Science 256,228 254,853 Non-Affiliate Debt Investments — Sustainability — 21.2 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 4.33 % December 1, 2026 3,750 3,695 3,695 Term Loan 15.25 % Prime 6.75 % 10.00 % - 4.33 % December 1, 2026 3,750 3,695 3,695 Nexii Building Solutions, Inc. (2)(12)(13)(14)(18) Other Sustainability Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,759 8,431 2,477 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,759 8,229 2,418 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,759 8,229 2,418 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 5,840 5,480 1,610 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 5,840 5,480 1,610 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 764 726 213 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 609 578 170 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 304 288 85 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 301 286 84 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 181 172 50 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 833 791 232 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 1,134 1,083 318 Term Loan 15.50 % (11) Fixed - - - - April 30, 2024 418 397 117 Term Loan 15.50 % (11) Fixed - - - - April 30, 2024 552 502 147 Term Loan 15.50 % (11) Fixed - - - - April 30, 2024 411 405 119 Term Loan 15.50 % (11) Fixed - - - - April 30, 2024 487 486 143 Soli Organic, Inc. (2)(12) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % April 1, 2026 5,000 4,967 4,967 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % April 1, 2026 2,500 2,483 2,483 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % May 1, 2026 5,000 4,964 4,964 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % May 1, 2026 2,500 2,482 2,482 Term Loan 14.00 % Prime 5.50 % 11.75 % - 2.75 % December 1, 2026 5,000 4,942 4,942 Term Loan 14.00 % Prime 5.50 % 11.75 % - 2.75 % December 1, 2026 2,500 2,471 2,471 Temperpack Technologies, Inc. (2)(12) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,697 3,697 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,697 3,697 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 7,500 7,386 7,386 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,693 3,693 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,693 3,693 Term Loan 14.50 % Prime 6.00 % 10.00 % - 2.00 % January 1, 2029 4,500 4,448 4,448 Term Loan 14.50 % Prime 6.00 % 10.00 % - 2.00 % January 1, 2029 2,000 1,977 1,977 Total Non-Affiliate Debt Investments — Sustainability 99,853 70,501 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) March 31, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Debt Investments — Technology — 77.6 Axiom Space, Inc. (2)(12) Communications Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,625 5,597 5,597 Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,625 5,597 5,597 Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,625 5,597 5,597 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Term Loan 15.75 % Prime 7.25 % 10.50 % - 3.00 % May 1, 2026 3,033 3,009 3,009 Clara Foods Co. (2)(12) Consumer-related Technologies Term Loan 14.25 % Prime 5.75 % 9.00 % - 5.50 % August 1, 2025 1,417 1,408 1,408 Term Loan 14.25 % Prime 5.75 % 9.00 % - 5.50 % August 1, 2025 1,417 1,408 1,408 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 3,750 3,729 3,729 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 1,250 1,243 1,243 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 3,750 3,729 3,729 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 1,250 1,243 1,243 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 3,750 3,729 3,729 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 1,250 1,243 1,243 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % January 1, 2028 3,750 3,716 3,716 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % January 1, 2028 3,750 3,716 3,716 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % April 1, 2028 3,750 3,708 3,708 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2028 3,750 3,709 3,709 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2028 3,750 3,709 3,709 Havenly, Inc. (2)(12) Consumer-related Technologies Term Loan 13.50 % Prime 5.00 % 5.00 % - 4.00 % March 1, 2027 2,000 1,505 1,505 Term Loan 13.50 % Prime 5.00 % 5.00 % - 4.00 % March 1, 2027 3,000 2,258 2,258 Term Loan 12.00 % Prime 3.50 % 10.50 % - 7.78 % February 1, 2028 2,813 2,813 2,813 Term Loan 12.00 % Prime 3.50 % 10.50 % - 7.78 % February 1, 2028 2,813 2,813 2,813 Lyrical Foods, Inc. (2)(12) Consumer-related Technologies Term Loan 12.00 % Prime 3.50 % 9.00 % - 1.00 % September 1, 2027 2,500 2,590 2,435 MyForest Foods Co. (2)(12) Consumer-related Technologies Term Loan 15.25 % Prime 6.75 % 10.00 % - 3.00 % October 1, 2025 3,000 2,986 2,986 Term Loan 15.25 % Prime 6.75 % 10.00 % - 3.00 % October 1, 2025 1,500 1,493 1,493 NextCar Holding Company, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 5,744 5,744 5,014 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,298 2,298 2,006 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,872 2,872 2,507 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 3,446 3,446 3,009 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,872 2,872 2,507 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,872 2,872 2,507 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 5,744 5,744 5,014 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,872 2,872 2,507 Optoro, Inc. (2)(12) Consumer-related Technologies Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % August 1, 2027 2,500 2,424 2,424 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % July 1, 2028 1,875 1,791 1,791 Unagi, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 1,254 1,086 570 Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 627 543 285 Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 627 543 285 Liqid, Inc. (2)(12) Networking Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 833 822 822 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 833 822 822 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 417 410 410 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 417 410 410 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 417 403 403 BriteCore Holdings, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 5,000 4,899 4,899 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,467 2,467 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,467 2,467 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,467 2,467 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % April 1, 2029 2,500 2,464 2,464 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) March 31, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Dropoff, Inc. (2)(12) Software Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % April 1, 2026 6,701 6,607 6,303 Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % April 1, 2026 6,185 6,098 5,819 Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % August 1, 2026 2,577 2,541 2,425 Kodiak Robotics, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 10,000 9,912 9,540 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 10,000 9,912 9,540 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 5,000 4,956 4,770 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 5,000 4,956 4,770 Lemongrass Holdings, Inc. (2)(12) Software Term Loan 15.00 % Prime 6.50 % 9.75 % - 2.50 % March 1, 2026 5,000 4,977 4,977 Term Loan 15.00 % Prime 6.50 % 9.75 % - 2.50 % March 1, 2026 2,500 2,489 2,489 Lytics, Inc. (2)(12) Software Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % November 1, 2026 2,500 2,473 2,473 Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % December 1, 2026 1,250 1,239 1,239 Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % April 1, 2027 1,000 994 994 Mirantis, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,783 4,783 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,919 4,919 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,919 4,919 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,919 4,919 Noodle Partners, Inc. (2)(12) Software Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 10,000 9,896 9,896 Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 5,000 4,947 4,947 Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 5,000 4,947 4,947 Reputation Institute, Inc. (2)(12) Software Term Loan 15.75 % Prime 7.25 % 10.50 % - 3.00 % August 1, 2025 3,233 3,182 3,182 Slingshot Aerospace, Inc. (2)(12) Software Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,965 4,965 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,965 4,965 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,965 4,965 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,965 4,965 Supply Network Visibility Holdings LLC (2)(12) Software Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 2,500 2,458 2,458 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 3,500 3,490 3,490 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 2,500 2,493 2,493 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 1,500 1,496 1,496 Viken Detection Corporation (2)(12) Software Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 5,000 4,779 4,779 Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 2,500 2,470 2,470 Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 2,500 2,470 2,470 Total Non-Affiliate Debt Investments — Technology 264,468 257,817 Non-Affiliate Debt Investments — Healthcare information and services — 21.0 Hound Labs inc. (2) (12) Diagnostics Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 2,500 2,487 2,487 Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 2,500 2,487 2,487 Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 5,000 4,973 4,973 Parse Biosciences, Inc. (2)(12) Diagnostics Term Loan 11.75 % Prime 3.25 % 11.50 % - 5.00 % January 1, 2028 5,000 4,639 4,639 Term Loan 11.75 % Prime 3.25 % 11.50 % - 5.00 % January 1, 2028 5,000 4,890 4,890 BrightInsight, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 7,000 6,727 6,727 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 3,500 3,466 3,466 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 3,500 3,466 3,466 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % April 1, 2028 2,750 2,713 2,713 Elligo Health Research, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 10,000 9,666 9,666 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,930 4,930 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,930 4,930 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,930 4,930 SafelyYou, Inc. (2)(12) Software Term Loan 11.75 % Prime 3.25 % 11.00 % - 5.00 % June 1, 2027 5,000 4,654 4,654 Term Loan 11.75 % Prime 3.25 % 11.00 % - 5.00 % June 1, 2027 5,000 4,924 4,924 Total Non-Affiliate Debt Investments — Healthcare information and services 69,882 69,882 Total Non- Affiliate Debt Investments 690,431 653,053 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) March 31, 2024 (Dollars in thousands) Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrant Investments — 7.2 Non-Affiliate Warrants — Life Science — 2.0 Avalo Therapeutics, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 117 311 — Castle Creek Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 7,404 214 220 Emalex Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 110,402 176 135 Imunon, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 19,671 65 — KSQ Therapeutics, Inc. (2) (12) Biotechnology Preferred Stock Warrant 48,076 50 54 Mustang Bio, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 16,611 146 — Native Microbials, Inc (2)(12) Biotechnology Preferred Stock Warrant 103,679 64 80 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Common Stock Warrant 299,848 160 364 Provivi, Inc. (2)(12) Biotechnology Common Stock Warrant 175,098 278 — Provivi, Inc. (2)(12) Biotechnology Preferred Stock Warrant 691,895 312 232 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Common Stock Warrant 318,181 264 116 Tallac Therapeutics, Inc. (2)(12) Biotechnology Preferred Stock Warrant 1,600,002 194 175 Xeris Pharmaceuticals, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 126,000 72 26 AccuVein Inc. (2)(12) Medical Device Common Stock Warrant 271 7 — Aerin Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 1,818,183 66 1,046 Aerobiotix, LLC (2)(12) Medical Device Preferred Stock Warrant 8,800 48 10 Canary Medical Inc. (2)(12) Medical Device Preferred Stock Warrant 12,153 86 1,299 Candesant Biomedical, Inc. (2)(12) Medical Device Preferred Stock Warrant 93,336 152 138 Ceribell, Inc. (2)(12) Medical Device Preferred Stock Warrant 219,866 139 267 Cognoa, Inc. (2)(12) Medical Device Common Stock Warrant 30,585 — — Cognoa, Inc. (2)(12) Medical Device Preferred Stock Warrant 4,635,992 162 182 Conventus Orthopaedics, Inc. (2)(12) Medical Device Preferred Stock Warrant 9,313,541 256 247 CSA Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 3,341,376 174 128 CVRx, Inc. (2)(5)(12) Medical Device Common Stock Warrant 47,410 76 382 Infobionic, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,010,424 124 50 Magnolia Medical Technologies, Inc. (2)(12) Medical Device Preferred Stock Warrant 809,931 195 374 Meditrina, Inc. (2)(12) Medical Device Preferred Stock Warrant 233,993 83 54 MicroTransponder, Inc. (2)(12) Medical Device Preferred Stock Warrant 103,172 47 48 Scientia Vascular, Inc (2)(12) Medical Device Preferred Stock Warrant 34,410 103 329 Sonex Health, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,637,041 275 276 VERO Biotech LLC (2)(12) Medical Device Preferred Stock Warrant 4,109 432 368 Swift Health Systems Inc. (2)(12) Medical Device Preferred Stock Warrant 135,484 71 2 Total Non-Affiliate Warrants — Life Science 4,802 6,602 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) March 31, 2024 (Dollars in thousands) Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrants — Sustainability — 0.2 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Preferred Stock Warrant 400,000 81 74 LiquiGlide, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 61,359 39 51 Nexii Building Solutions, Inc. (2)(12)(14)(18) Other Sustainability Common Stock Warrant 215,171 490 — Soli Organic, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 681 216 350 Temperpack Technologies, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 46,311 175 84 Total Non-Affiliate Warrants — Sustainability 1,001 559 Non-Affiliate Warrants — Technology — 4.6 Axiom Space, Inc. (2)(12) Communications Common Stock Warrant 1,991 46 62 Intelepeer Holdings, Inc. (2)(12) Communications Preferred Stock Warrant 2,936,535 137 2,894 PebblePost, Inc. (2)(12) Communications Preferred Stock Warrant 598,850 92 132 Alula Holdings, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 20,000 93 3 Aterian, Inc. (2)(5)(12) Consumer-related Technologies Common Stock Warrant 6,140 195 — Caastle, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 268,591 68 2,167 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 75,997 22 28 Clara Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 46,745 30 124 CZV, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 65,569 81 73 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 37,282 95 259 Havenly, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 1,312,500 2,947 2,260 MyForest Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 250 29 58 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 12,618 188 — NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 1,224,752 9 — Optoro, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 11,550 179 145 Primary Kids, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 553,778 57 593 Quip NYC Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 6,191 325 232 Unagi, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 171,081 32 — Updater, Inc.(2)(12) Consumer-related Technologies Preferred Stock Warrant 114,659 34 — CPG Beyond, Inc. (2)(12) Data Storage Preferred Stock Warrant 500,000 241 298 Silk, Inc. (2)(12) Data Storage Preferred Stock Warrant 394,110 175 128 Global Worldwide LLC (2)(12) Internet and Media Preferred Stock Warrant 245,810 74 63 Rocket Lawyer Incorporated (2)(12) Internet and Media Preferred Stock Warrant 261,721 92 323 Skillshare, Inc. (2)(12) Internet and Media Preferred Stock Warrant 139,074 162 1,206 Liqid, Inc. (2)(12) Networking Preferred Stock Warrant 344,102 364 224 Halio, Inc. (2)(12) Power Management Common Stock Warrant 38,241,466 1,585 2,700 Avalanche Technology, Inc. (2)(12) Semiconductors Preferred Stock Warrant 5,938 45 — BriteCore Holdings, Inc. (2)(12) Software Preferred Stock Warrant 161,215 98 136 Dropoff, Inc. (2)(12) Software Common Stock Warrant 516,732 455 56 E La Carte, Inc. (2)(5)(12) Software Common Stock Warrant 147,361 60 — Everstream Holdings, LLC (2)(12) Software Preferred Stock Warrant 350,000 70 63 Kodiak Robotics, Inc. (2)(12) Software Preferred Stock Warrant 639,918 273 11 Lemongrass Holdings, Inc. (2)(12) Software Preferred Stock Warrant 101,308 34 121 Lotame Solutions, Inc. (2)(12) Software Preferred Stock Warrant 71,305 18 42 Lytics, Inc. (2)(12) Software Preferred Stock Warrant 85,543 43 — Mirantis, Inc. (2)(12) Software Common Stock Warrant 948,275 220 253 Noodle Partners, Inc. (2)(12) Software Preferred Stock Warrant 84,037 116 3 Reputation Institute, Inc. (2)(12) Software Preferred Stock Warrant 4,104 66 83 Revinate Holdings, Inc. (2)(12) Software Preferred Stock Warrant 682,034 44 93 SIGNiX, Inc. (12) Software Preferred Stock Warrant 186,235 225 — Slingshot Aerospace, Inc. (2)(12) Software Preferred Stock Warrant 309,208 123 85 Supply Network Visibility Holdings LLC (2)(12) Software Preferred Stock Warrant 682 64 138 Topia Mobility, Inc. (2)(12) Software Preferred Stock Warrant 3,049,607 138 — Viken Detection Corporation (2)(12) Software Preferred Stock Warrant 345,443 120 211 xAd, Inc. (2)(12) Software Preferred Stock Warrant 4,343,348 177 8 Total Non-Affiliate Warrants — Technology 9,741 15,275 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) March 31, 2024 (Dollars in thousands) Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrants — Healthcare information and services — 0.4 Hound Labs, Inc (2)(12) Diagnostics Preferred Stock Warrant 171,370 47 12 Parse Biosciences, Inc. (2)(12) Diagnostics Common Stock Warrant 32,244 70 70 Parse Biosciences, Inc. (2)(12) Diagnostics Preferred Stock Warrant 184,253 166 171 Kate Farms, Inc. (2)(12) Other Healthcare Preferred Stock Warrant 82,965 102 949 BrightInsight, Inc. (2)(12) Software Preferred Stock Warrant 85,066 168 — Elligo Health Research, Inc. (2)(12) Software Preferred Stock Warrant 652,250 191 98 Medsphere Systems Corporation (2)(12) Software Preferred Stock Warrant 7,097,792 60 134 SafelyYou, Inc. (2)(12) Software Preferred Stock Warrant 150,353 163 58 Total Non-Affiliate Warrants — Healthcare information and services 967 1,492 Total Non-Affiliate Warrants 16,511 23,928 Non-Affiliate Other Investments — Life Science — 1.0 Lumithera, Inc. (12) Medical Device Royalty Agreement 1,200 100 Robin Healthcare, Inc. (2)(12) Medical Device Royalty Agreement 7,181 3,247 ZetrOZ, Inc. (12) Medical Device Royalty Agreement — — Total Non-Affiliate Other Investments 8,381 3,347 Non-Affiliate Equity — 1.4 Cadrenal Therapeutics, Inc. (5) Biotechnology Common Stock 600,000 — 367 Castle Creek Biosciences, Inc. (12) Biotechnology Common Stock 1,162 250 250 Emalex Biosciences, Inc. (12) Biotechnology Common Stock 32,831 355 355 Axiom Space, Inc. (12) Communications Preferred Stock 1,810 261 306 Getaround, Inc. (2)(5) Consumer-related Technologies Common Stock 87,082 253 27 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock 2,688,971 89 — SnagAJob.com, Inc. (12) Consumer-related Technologies Common Stock 82,974 10 80 Lumithera, Inc. (12) Medical Device Common Stock 392,651 2,000 1,700 Tigo Energy, Inc. (5) Other Sustainability Common Stock 5,205 111 8 Decisyon, Inc. (12) Software Preferred Stock 280,000 2,800 1,281 Lotame, Inc. (12) Software Preferred Stock 66,127 4 193 Total Non-Affiliate Equity 6,133 4,567 Total Non-Affiliate Portfolio Investment Assets $ 721,456 $ 684,895 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) March 31, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Controlled Affiliate Investments — 3.8 Non-Controlled Affiliate Debt Investments — Life Sciences — 3.8 Evelo Biosciences, Inc. (2)(5)(12)(13) Biotechnology Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 5,712 5,228 2,790 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 8,568 7,880 4,207 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 3,427 3,137 1,674 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 3,427 3,137 1,674 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 2,285 2,091 1,116 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 2,285 2,091 1,116 Total Non-Controlled Affiliate Debt Investments 23,564 12,577 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-controlled Affiliate Equity — Life Sciences — 0.0 Aulea Medical, Inc. (12)(16) Medical Device Common Stock 660,537 — — Evelo Biosciences, Inc. (5)(12) Biotechnology Common Stock 2,164,502 5,000 — Total Non-Controlled Affiliate Equity 5,000 — Non-controlled Affiliate Warrants — Life Sciences — 0.0 Evelo Biosciences, Inc. (2)(5)(12) Biotechnology Common Stock 23,196 125 — Total Non-Controlled Affiliate Warrants 125 — Total Non-Controlled Affiliate Portfolio Investment Assets $ 28,689 $ 12,577 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Controlled Affiliate Investments — 4.1 Controlled Affiliate Debt Investments — Technology — 1.5 Better Place Forests Co. (12) Consumer-related Technologies Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - 2.78 % August 1, 2029 3,658 3,698 3,455 Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - 2.78 % August 1, 2029 1,829 1,807 1,688 Total Controlled Affiliate Debt Investments 5,505 5,143 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Controlled Affiliate Equity — Technology — 0.8 Better Place Forests Co. (12) Consumer-related Technologies Common Stock 2,278,272 2,060 659 Better Place Forests Co. (12) Consumer-related Technologies Preferred Stock 4,458,452 2,000 1,997 Total Controlled Affiliate Equity 4,060 2,656 Controlled Affiliate Other Investments — Life Sciences — 1.8 HIMV LLC (12)(17) Biotechnology Other Investment 5,463 5,845 Total Controlled Affiliate Other 5,463 5,845 Total Controlled Affiliate Portfolio Investment Assets $ 15,028 $ 13,644 Total Portfolio Investment Assets — 214.1 $ 765,173 $ 711,116 ( 1 All investments of the Company are in entities which are organized under the laws of the United States and have a principal place of business i

Note 1 - Organization

Note 1 - Organization	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Horizon Technology Finance Corporation (the “Company”) was organized as a Delaware corporation on March 16, 2010 1940 1986, not On October 28, 2010, Horizon Credit II LLC (“Credit II”) was formed as a Delaware limited liability company on June 28, 2011, not The Company formed Horizon Funding 2019‑1 “2019‑1 May 2, 2019 2019‑1 May 15, 2019 “2019‑1 2019‑1 “2019‑1 2019‑1 2019‑1 August 13, 2019 ( “2019 2019 1 March 31, 2024. Horizon Funding I, LLC (“HFI”) was formed as a Delaware limited liability company on May 9, 2018, not April 21, 2020, The Company formed Horizon Funding 2022‑1 “2022‑1 September 30, 2022 2022‑1 October 18, 2022 ( “2022‑1 2022‑1 “2022‑1 2022‑1 2022‑1 2022 The Company has established wholly owned subsidiaries, which are structured as Delaware limited liability companies, either to hold assets of portfolio companies acquired in connection with a foreclosure or bankruptcy or to hold equity in portfolio companies which the Company may The Company, together with its co-lender to IMV, established HIMV LLC, a Delaware limited liability company to purchase and sell the assets of IMV, a borrower of the Company. HIMV LLC is 70% owned by the Company and 30% owned by the co-lender. The Company’s investment strategy is to maximize the investment portfolio’s return by generating current income from the debt investments the Company makes and capital appreciation from the warrants the Company receives when making such debt investments. The Company has entered into an investment management agreement with Horizon Technology Finance Management LLC (the “Advisor”) under which the Advisor manages the day-to-day operations of, and provides investment advisory services to, the Company.

Note 2 - Basis of Presentation

Note 2 - Basis of Presentation and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	Note 2. The consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the requirements for reporting on Form 10‑Q 6 10 X X” 1933, not may December 31, 2023 Principles of consolidation As required under GAAP and Regulation S- X, Assets related to transactions that do not 860, Transfers and Servicing 2019‑1 2022 1 not Use of estimates In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments. Fair value The Company records all of its investments at fair value in accordance with relevant GAAP, which establishes a framework used to measure fair value and requires disclosures for fair value measurements. The Company has categorized its investments carried at fair value, based on the priority of the valuation technique, into a three 6. not The availability of observable inputs can vary depending on the financial instrument and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new, whether the product is traded on an active exchange or in the secondary market and the current market conditions. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for financial instruments classified as Level 3. See Note 6 Segments The Company has determined that it has a single reporting segment and operating unit structure. The Company lends to and invests in portfolio companies in various technology, life science, healthcare information and services and sustainability industries. The Company separately evaluates the performance of each of its lending and investment relationships. However, because each of these debt investments and investment relationships has similar business and economic characteristics, they have been aggregated into a single lending and investment segment. Investments Investments are recorded at fair value. Pursuant to the amended SEC Rule 2a 5 1940 July 29, 2022, Interest on debt investments is accrued and included in income based on contractual rates applied to principal amounts outstanding. Interest income is determined using a method that results in a level rate of return on principal amounts outstanding. Generally, when a debt investment becomes 90 not may may March 31, 2024 four December 31, 2023 four three March 31, 2024 2023, not The Company has a limited number of debt investments in its portfolio that contain a PIK provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. For the three March 31, 2024 2023, not three March 31, 2024 one three March 31, 2024 three March 31, 2023, two three March 31, 2023, The Company receives a variety of fees from borrowers in the ordinary course of conducting its business, including advisory fees, commitment fees, amendment fees, non-utilization fees, success fees and prepayment fees. In a limited number of cases, the Company may Certain debt investment agreements also require the borrower to make an ETP, that is accrued into interest receivable and taken into income over the life of the debt investment to the extent such amounts are expected to be collected. The Company will generally cease accruing the income if there is insufficient value to support the accrual or the Company does not not three March 31, 2024 2023 In connection with substantially all lending arrangements, the Company receives warrants to purchase shares of stock from the borrower. The warrants are recorded as assets at estimated fair value on the grant date using the Black-Scholes valuation model. The warrants are considered loan fees and are recorded as unearned income on the grant date. The unearned income is recognized as interest income over the contractual life of the related debt investment in accordance with the Company’s income recognition policy. Subsequent to debt investment origination, the fair value of the warrants is determined using the Black-Scholes valuation model. Any adjustment to fair value is recorded through earnings as net unrealized appreciation or depreciation on investments. Gains and losses from the disposition of the warrants or stock acquired from the exercise of warrants are recognized as realized gains and losses on investments. Realized gains or losses on the sale of investments, or upon the determination that an investment balance, or portion thereof, is not Debt issuance costs Debt issuance costs are fees and other direct incremental costs incurred by the Company in obtaining debt financing from its lenders and issuing debt securities. The unamortized balance of debt issuance costs as of March 31, 2024 December 31, 2023 March 31, 2024 December 31, 2023 three March 31, 2024 2023 Income taxes As a BDC, the Company has elected to be treated as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to qualify as a RIC and to avoid the imposition of corporate-level income tax on the portion of its taxable income distributed to stockholders, among other things, the Company is required to meet certain source of income and asset diversification requirements and to timely distribute dividends out of assets legally available for distribution to its stockholders of an amount generally at least equal to 90% no 946, Financial Services Investment Companies no Depending on the level of taxable income earned in a tax year, the Company may three March 31, 2024 2023 The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than- not” 740, Income Taxes 946. not not March 31, 2024 December 31, 2023 2024, 2023, 2022 2021 Distributions Distributions to common stockholders are recorded on the declaration date. The amount to be paid out as distributions is determined by the Board. Net realized capital gains, if any, may may The Company has adopted a dividend reinvestment plan that provides for reinvestment of cash distributions on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Board declares a cash distribution, then stockholders who have not may Stockholders Equity On August 2, 2021, “2021 2021 may On September 22, 2023, 2021 “2023 2021 2023 may may 415 During the three March 31, 2024 2023 During the three March 31, 2023 2021 The Company generally uses net proceeds from these offerings to make investments, to pay down liabilities and for general corporate purposes. As of March 31, 2024 2023 Stock Repurchase Program On April 26, 2024, may, not 10b‑18 1934, 1940 June 30, 2025 $5.0 three March 31, 2024 2023 not March 31, 2024 Transfers of financial assets Assets related to transactions that do not 860, Transfers and Servicing not Transfers of financial assets are accounted for as sales when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when ( 1 2 3 not Recently adopted accounting pronouncement In June 2022, No. 2022 03, 2022 03” 2022 03 2022 03 December 15, 2023, 2022 03 not

Note 3 - Related Party Transact

Note 3 - Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 3. Investment Management Agreement At a meeting of the stockholders convened on May 25, 2023 June 28, 2023, June 30, 2023 ( March 7, 2019. The Advisor’s services under the Investment Management Agreement are not not two The base management fee is calculated at an annual rate of 2.00% of the Company’s gross assets (less cash and cash equivalents) including any assets acquired with the proceeds of leverage; provided, that, to the extent the Company’s gross assets (less cash and cash equivalents) exceed $250 $250 The base management fee payable at March 31, 2024 December 31, 2023 three March 31, 2024 2023 The incentive fee has two The first zero not no 1.75%, 2.1875% 20.00% not Pre-Incentive Fee Net Investment Income does not may 2.00% three The incentive fee on Pre-Incentive Fee Net Investment Income is subject to a fee cap and deferral mechanism which is determined based upon a look-back period of up to three 11 may 20.00% zero not three The second 20.00% not The performance based incentive fee expense was $0.3 million and $3.0 million for the three March 31, 2024 2023, three March 31, 2024 2023 not may three March 31, 2024 December 31, 2025, March 31, 2026, June 30, 2026, September 30, 2026, December 31, 2026, March 31, 2027, March 31, 2024 December 31, 2023 Administration Agreement The Company entered into an administration agreement (the “Administration Agreement”) with the Advisor to provide administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Advisor for the Company’s allocable portion of overhead and other expenses incurred by the Advisor in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions and the Company’s allocable portion of the costs of compensation and related expenses of the Company’s Chief Financial Officer and Chief Compliance Officer and their respective staffs. The administrative fee expense was $0.4 million for the three March 31, 2024 2023 March 31, 2024 December 31, 2023

Note 4 - Investments

Note 4 - Investments	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Investment Holdings [Text Block]	Note 4. The following table shows the Company’s investments as of March 31, 2024 December 31, 2023 March 31, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Investments Debt $ 719,500 $ 670,773 $ 721,231 $ 670,172 Warrants 16,636 23,928 16,526 24,594 Other 13,844 9,192 6,982 6,430 Equity 15,193 7,223 14,443 7,889 Total investments $ 765,173 $ 711,116 $ 759,182 $ 709,085 The following table shows the Company’s investments by industry sector as of March 31, 2024 December 31, 2023 March 31, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Life Science Biotechnology $ 142,108 $ 124,741 $ 145,544 $ 117,781 Medical Device 164,060 161,155 147,064 145,019 Technology Communications 17,327 20,185 19,192 22,188 Consumer-Related 105,165 99,876 105,669 101,327 Data Storage 416 426 417 418 Internet and Media 328 1,592 329 1,582 Networking 3,231 3,091 5,451 5,297 Power Management 1,585 2,700 1,585 2,700 Semiconductors 45 — 45 — Software 159,094 154,908 164,133 160,749 Sustainability Energy Efficiency 111 8 111 13 Other Sustainability 100,854 71,060 98,906 80,370 Healthcare Information and Services Diagnostics 19,759 19,729 19,735 19,701 Other 102 949 102 1,366 Software 50,988 50,696 50,899 50,574 Total investments $ 765,173 $ 711,116 $ 759,182 $ 709,085

Note 5 - Transactions With Affi

Note 5 - Transactions With Affiliated Companies	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Investments in and Advances to Affiliates, Schedule of Investments [Text Block]	Note 5. A non-controlled affiliated company is generally a portfolio company in which the Company owns 5% not 25% Transactions related to investments in non-controlled affiliated companies for the three March 31, 2024 Three months ended March 31, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized March 31, Interest Company 2023 Purchases Payments fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Aulea Medical, Inc. $ — $ 3 $ — $ — $ — $ — $ (3 ) $ — $ — Evelo Biosciences, Inc. 222 — — — — 2,568 — 2,790 — 336 12 — — — 3,859 — 4,207 — 133 — — — — 1,541 — 1,674 — 133 — — — — 1,541 — 1,674 — 88 — — — — 1,028 — 1,116 — 88 — — — — 1,028 — 1,116 — 132 — — — — (132 ) — — — Total non-controlled affiliates $ 1,132 $ 15 $ — $ — $ — $ 11,433 $ (3 ) $ 12,577 $ — Transactions related to investments in non-controlled affiliated companies for the three March 31, 2023 Three months ended March 31, 2023 Fair value at Transfers Net Fair value at Portfolio December 31, in/(out) at Discount unrealized Net realized March 31, Interest Company 2022 Purchases Sales fair value Accretion gain/(loss) gain/(loss) 2023 income (In thousands) Cadrenal Therapeutics, Inc. — — — — — 846 — 846 — Total non-controlled affiliates $ — $ — $ — $ — $ — $ 846 $ — $ 846 $ — A controlled affiliated company is generally a portfolio company in which the Company owns more than 25% Transactions related to investments in controlled affiliated companies for the three March 31, 2024 Three months ended March 31, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized March 31, Interest Company 2023 Purchases Payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,339 $ — $ — $ 111 $ — $ 2 $ 3 $ — $ 3,455 $ 116 1,630 — — 55 — 2 1 — 1,688 61 3,024 750 — — — — (1,118 ) — 2,656 — HIMV LLC 6,230 227 (547 ) — — — (65 ) — 5,845 — Total controlled affiliates $ 14,223 $ 977 $ (547 ) $ 166 $ — $ 4 $ (1,179 ) $ — $ 13,644 $ 177 For the three March 31, 2023,

Note 6 - Fair Value

Note 6 - Fair Value	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 6. Prior to July 30, 2022, 2a 5 1940 July 29, 2022, twelve The Company uses fair value measurements made by the valuation designee to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is best determined based upon quoted market prices. However, in certain instances, there are no not may not Fair value measurements focus on exit prices in an orderly transaction (that is, not may The Company’s fair value measurements are classified into a fair value hierarchy in accordance with ASC Topic 820, Fair Value Measurement three Level 1 Quoted prices in active markets for identical assets and liabilities. Level 2 Observable inputs other than Level 1 not Level 3 Unobservable inputs that are supported by little or no 3 Due to the inherent uncertainty of determining the fair value of investments that do not may may may may Cash and interest receivable: not 1 Money market funds: 2 Debt investments: 3 Under certain circumstances, the Company may Warrant investments: ● Underlying asset value of the issuer is estimated based on information available, including any information regarding the most recent rounds of borrower funding. Significant increases (decreases) in this unobservable input would result in a significantly higher (lower) fair value measurement. ● Volatility, or the amount of uncertainty or risk about the size of the changes in the warrant price, is based on indices of publicly traded companies similar in nature to the underlying company issuing the warrant. A total of seven ● The risk-free interest rates are derived from the U.S. Treasury yield curve. The risk-free interest rates are calculated based on a weighted average of the risk-free interest rates that correspond closest to the expected remaining life of the warrant. ● Other adjustments, including a marketability discount on private company warrants, are estimated based on management’s judgment about the general industry environment. ● Historical portfolio experience on cancellations and exercises of the Company’s warrants are utilized as the basis for determining the estimated time to exit of the warrants in each financial reporting period. Warrants may Under certain circumstances the Company may may The fair value of the Company’s warrants held in publicly traded companies is determined based on inputs that are readily available in public markets or can be derived from information available in public markets. Therefore, the Company has categorized these warrants as Level 2 3 Equity investments: third may 3 1 Other investments: 3 The following tables detail the assets that are carried at fair value and measured at fair value on a recurring basis as of March 31, 2024 December 31, 2023 March 31, 2024 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 670,773 $ 670,773 Warrant investments — 772 23,156 23,928 Other investments — — 9,192 9,192 Equity investments 398 — 6,825 7,223 Total investments $ 398 $ 772 $ 709,946 $ 711,116 December 31, 2023 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 670,172 $ 670,172 Warrant investments — 1,619 22,975 24,594 Other investments — — 6,430 6,430 Equity investments 608 — 7,281 7,889 Total investments $ 608 $ 1,619 $ 706,858 $ 709,085 The following tables provide a summary of quantitative information about the Company’s Level 3 March 31, 2024 December 31, 2023 may The following table is not 3 March 31, 2024 March 31, 2024 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 619,773 Discounted Expected Future Cash Flows Hypothetical Market Yield 11% – 20% 15 % 51,000 Multiple Probability Weighted Cash Flow Model Probability Weighting 5% - 95% 44 % Warrant investments 23,094 Black-Scholes Valuation Model Price Per Share 0.000 –1,898.58 $ 61.04 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 18 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 9,192 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 75 % Equity investments 6,825 Last Equity Financing Price Per Share 0.00 215.03 $ 18.21 Total Level 3 investments $ 709,946 ( 1 Weighted average is calculated by multiplying (a) the unobservable input for each investment in the investment type by (b) ( 1 2 The following table is not 3 December 31, 2023 December 31, 2023 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 617,529 Discounted Expected Future Cash Flows Hypothetical Market Yield 11% – 24% 15 % 52,643 Multiple Probability Weighted Cash Flow Model Probability Weighting 20% - 100% 50 % Warrant investments 22,913 Black-Scholes Valuation Model Price Per Share 0.000 –1,899 $ 64.95 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 18 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 6,430 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 81 % Equity investments 7,281 Last Equity Financing Price Per Share 0.56 215.03 $ 17.15 Total Level 3 investments $ 706,858 ( 1 Weighted average is calculated by multiplying (a) the unobservable input for each investment in the investment type by (b) ( 1 2 Borrowings: 2 2026 7 March 31, 2024 2026 1 2027 7 March 31, 2024 2027 1 March 31, 2024 2022 3 not Off-balance-sheet instruments: 3 The following table shows a reconciliation of the beginning and ending balances for Level 3 three March 31, 2024 Three months ended March 31, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 670,172 $ 22,975 $ 7,281 $ 6,430 $ 706,858 Purchase of investments 22,177 — 750 392 23,319 Warrants received and classified as Level 3 — 128 — — 128 Principal payments received on investments (19,080 ) — — (563 ) (19,643 ) Payment-in-kind interest on investments 1,382 — — — 1,382 Proceeds from sale of investments (41 ) — — — (41 ) Net realized gain (loss) on investments 38 (17 ) — — 21 Unrealized (depreciation) appreciation included in earnings (1,509 ) 70 (1,206 ) (258 ) (2,903 ) Transfer out of debt investments (3,191 ) — — 3,191 — Other 825 — — — 825 Level 3 assets, end of period $ 670,773 $ 23,156 $ 6,825 $ 9,192 $ 709,946 During the three March 31, 2024 one 3. one 3 no three March 31, 2024, 3. The change in unrealized depreciation included in the consolidated statement of operations attributable to Level 3 March 31, 2024 The following table shows a reconciliation of the beginning and ending balances for Level 3 three March 31, 2023 Three months ended March 31, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 686,458 $ 26,145 $ 2,416 $ 1,300 $ 716,319 Purchase of investments 46,998 — 10 — 47,008 Warrants received and classified as Level 3 — 141 — — 141 Principal payments received on investments (39,756 ) — — — (39,756 ) Payment-in-kind interest on investments 1,204 — — — 1,204 Proceeds from sale of investments (6,508 ) (12 ) — — (6,520 ) Net realized gain (loss) on investments 7 (141 ) — — (134 ) Unrealized (depreciation) appreciation included in earnings (4,566 ) (1,490 ) 189 — (5,867 ) Transfer out of debt investments (295 ) (5 ) 300 — — Other 1,012 — — — 1,012 Level 3 assets, end of period $ 684,554 $ 24,638 $ 2,915 $ 1,300 $ 713,407 During the three March 31, 2023 3. The change in unrealized depreciation included in the consolidated statement of operations attributable to Level 3 March 31, 2023 The Company discloses fair value information about financial instruments, whether or not not The fair value amounts have been measured as of the reporting date and have not may As of March 31, 2024 December 31, 2023 Market risk The Company assumes interest rate risk (the risk that general interest rate levels will change) as a result of its normal operations. As a result, the fair values of the Company’s financial instruments may may

Note 7 - Borrowings

Note 7 - Borrowings	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 7. The following table shows the Company’s borrowings as of March 31, 2024 December 31, 2023 March 31, 2024 December 31, 2023 Total Balance Unused Total Balance Unused Commitment Outstanding Commitment Commitment Outstanding Commitment (In thousands) Key Facility $ 150,000 $ 60,000 $ 90,000 $ 150,000 $ 70,000 $ 80,000 NYL Facility 250,000 181,000 69,000 250,000 181,000 69,000 2022 Asset-Backed Notes 100,000 100,000 — 100,000 100,000 — 2027 Notes 57,500 57,500 — 57,500 57,500 — 2026 Notes 57,500 57,500 — 57,500 57,500 — Total before debt issuance costs 615,000 456,000 159,000 615,000 466,000 149,000 Unamortized debt issuance costs attributable to term borrowings — (3,510 ) — — (3,765 ) — Total borrowings outstanding, net $ 615,000 $ 452,490 $ 159,000 $ 615,000 $ 462,235 $ 149,000 As of March 31, 2024 1940 March 31, 2024 Credit Facilities Key Facility The Company entered into the Key Facility with Key effective November 4, 2013. June 29, 2023, may June 22, 2024 June 22, 2026. March 31, 2024 December 31, 2023. three March 31, 2024 2023 March 31, 2024 December 31, 2023 March 31, 2024 December 31, 2023 NYL Facility HFI entered into the NYL Facility with the NYL Noteholders for an aggregate purchase price of up to $100.0 million, with an accordion feature of up to $200.0 million at the mutual discretion and agreement of HSLFI and the NYL Noteholders. On June 1, 2018, three On February 25, 2022, three On May 24, 2023, June 2024 June 2029. May 24, 2023, 4.60% 3.50%, There were $181.0 million in advances made by the NYL Noteholders as of March 31, 2024 December 31, 2023 March 31, 2024 2023 March 31, 2024 December 31, 2023 March 31, 2024 December 31, 2023 Under the terms of the NYL Facility, the Company is required to maintain a reserve cash balance, which may March 31, 2024 December 31, 2023 Securitizations 2019 On August 13, 2019, 2019 2019 no August 13, 2019. 2019 November 22, 2023. The 2019 2019‑1 August 13, 2019, 2019 2019 July 15, 2021 September 15, 2027. As of December 31, 2023, 2019 2022 On November 9, 2022, 2022 2022 no November 9, 2022. The 2022 2022‑1 November 9, 2022, 2022 2022 November 15, 2024 November 15, 2030. As of March 31, 2024 December 31, 2023 2022 Under the terms of the 2022 2022 may 2022 March 31, 2024 December 31, 2023 Unsecured Notes 2026 On March 30, 2021, 2026 “2026 2026 2026 March 30, 2026 may March 30, 2023 2026 4.875% March 30, June 30, September 30 December 30 2026 2026 March 31, 2024 2026 2026 2027 On June 15, 2022, 2027 July 11, 2022, 30 “2027 2027 June 15, 2027 may June 15, 2024 2027 6.25% March 30, June 30, September 30 December 30 September 30, 2022. 2027 2027 March 31, 2024 2027 2027

Note 8 - Financial Instruments

Note 8 - Financial Instruments With Off-balance-sheet Risk	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Financial Instruments Disclosure [Text Block]	Note 8. In the normal course of business, the Company is party to financial instruments with off-balance-sheet risk to meet the financing needs of its borrowers. These financial instruments include commitments to extend credit and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the consolidated statement of assets and liabilities. The Company attempts to limit its credit risk by conducting extensive due diligence and obtaining collateral where appropriate. The balance of unfunded commitments to extend credit was $168.2 million and $180.5 million as of March 31, 2024 December 31, 2023 may not The following table provides the Company’s unfunded commitments by portfolio company as of March 31, 2024 December 31, 2023 March 31, 2024 December 31, 2023 Fair Value of Fair Value of Unfunded Unfunded Commitment Commitment Commitment Commitment Amount Liability Amount Liability (In thousands) (In thousands) BrightInsight, Inc. $ 15,500 $ 205 $ 15,500 $ 241 Britecore Holdings, Inc. 2,500 36 5,000 72 Candesant Biomedical Corporation 10,000 151 10,000 151 Ceribell, Inc. 21,000 120 — — Divergent Technologies, Inc. — — 11,250 118 Elligo Healthcare Research, Inc. 15,000 194 15,000 194 MicroTransponder, Inc. 22,500 — 22,500 — Mirantis, Inc. 15,000 136 15,000 136 Nexii Building Solutions, Inc. 486 — — — Optoro, Inc. 6,250 — 6,250 — Parse Biosciences, Inc. 15,000 251 15,000 251 SafelyYou, Inc. 20,000 270 20,000 270 Sonex Health, Inc. — — 15,000 176 Supply Network Visibility Holdings, LLC 10,000 35 10,000 35 Tallac Therapeutics, Inc. 5,000 229 10,000 229 Viken Detection Corporation 10,000 160 10,000 160 Total $ 168,236 $ 1,787 $ 180,500 $ 2,033 The table above also provides the fair value of the Company’s unfunded commitment liability as of March 31, 2024 December 31, 2023,

Note 9 - Concentrations of Cred

Note 9 - Concentrations of Credit Risk	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	Note 9. The Company’s debt investments consist primarily of loans to development-stage companies at various stages of development in the technology, life science, healthcare information and services and sustainability industries. Many of these companies may may The Company’s largest debt investments may five March 31, 2024 December 31, 2023 five March 31, 2024 December 31, 2023 No 10% March 31, 2024 December 31, 2023 five three March 31, 2024 2023 five three March 31, 2024 2023

Note 10 - Distributions

Note 10 - Distributions	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Equity [Text Block]	Note 10. The Company’s distributions are recorded on the declaration date. The following table summarizes the Company’s distribution activity for the three March 31, 2024 December 31, 2023 DRIP DRIP Date Amount Cash Shares Share Declared Record Date Payment Date Per Share Distribution Issued Value (In thousands, except share and per share data) Three Months Ended March 31, 2024 2/23/2024 5/17/2024 6/14/2024 $ 0.11 $ — — $ — 2/23/2024 4/18/2024 5/15/2024 0.11 — — — 2/23/2024 3/19/2024 4/16/2024 0.05 1,625 7,598 85 2/23/2024 3/19/2024 4/16/2024 0.11 3,574 16,717 188 $ 0.38 $ 5,199 24,315 $ 273 Year Ended December 31, 2023 10/27/2023 2/16/2024 3/15/2024 $ 0.11 $ 3,463 18,257 $ 210 10/27/2023 1/18/2024 2/14/2024 0.11 3,462 15,873 210 10/27/2023 12/19/2023 1/16/2024 0.11 3,472 14,563 199 10/27/2023 11/17/2023 12/15/2023 0.05 1,574 7,137 93 7/28/2023 11/17/2023 12/15/2023 0.11 3,463 15,701 206 7/28/2023 10/18/2023 11/15/2023 0.11 3,493 14,022 173 7/28/2023 9/19/2023 10/16/2023 0.11 3,445 15,067 184 4/28/2023 8/17/2023 9/15/2023 0.11 3,458 8,665 106 4/28/2023 7/18/2023 8/15/2023 0.11 3,427 8,307 105 4/28/2023 6/16/2023 7/14/2023 0.11 3,434 7,424 96 2/23/2023 5/18/2023 6/14/2023 0.11 3,087 7,128 86 2/23/2023 4/18/2023 5/16/2023 0.11 3,068 6,705 84 2/23/2023 3/17/2023 4/14/2023 0.11 3,035 6,894 81 $ 1.37 $ 41,881 145,743 $ 1,833 On April 26, 2024, Monthly distributions Ex-Dividend Date Record Date Payment Date Distributions Declared August 16, 2024 August 16, 2024 September 13, 2024 $ 0.11 July 17, 2024 July 17, 2024 August 15, 2024 $ 0.11 June 17, 2024 June 17, 2024 July 16, 2024 $ 0.11 After paying distributions of $0.33 per share and earning net investment income of $0.38 per share for the quarter, the Company’s undistributed spillover income as of March 31, 2024 not

Note 11 - Financial Highlights

Note 11 - Financial Highlights	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Investment Company, Financial Highlights [Text Block]	Note 11. The following table shows financial highlights for the Company: Three months ended March 31, 2024 2023 (In thousands, except share and per share data) Per share data: Net asset value at beginning of period $ 9.71 $ 11.47 Net investment income 0.38 0.46 Realized loss — (0.01 ) Unrealized depreciation on investments (0.12 ) (0.26 ) Net increase in net assets resulting from operations 0.26 0.19 Distributions declared (1) (0.38 ) (0.33 ) From net investment income (0.38 ) (0.33 ) From net realized gain on investments — — Return of capital — — Other (2) 0.05 0.01 Net asset value at end of period $ 9.64 $ 11.34 Per share market value, beginning of period $ 13.17 $ 11.60 Per share market value, end of period $ 11.37 $ 11.28 Total return based on a market value (3) (11.2 )% 0.1 % Shares outstanding at end of period 34,469,878 28,377,357 Ratios to average net assets: Expenses without incentive fee (4) 15.7 % 14.8 % Incentive fees (4) 0.4 % 3.7 % Net expenses (4) 16.1 % 18.5 % Net investment income with incentive fee (4) 15.4 % 16.3 % Net assets at the end of the period $ 332,121 $ 321,683 Average net asset value $ 328,051 $ 320,066 Average debt per share $ 13.61 $ 15.61 Portfolio turnover ratio 1.4 % (5) 4.2 % (5) ( 1 Distributions are determined based on taxable income calculated in accordance with income tax regulations, which may ( 2 Includes the impact of the different share amounts as a result of calculating per share data based on the weighted average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. The issuance of common stock on a per share basis reflects the incremental net asset value changes as a result of the issuance of common stock in the Company’s continuous public offering and pursuant to the Company’s distribution reinvestment plan. The issuance of common stock at an offering price, net of sales commissions and dealer manager fees, that is greater than the net asset value per share results in an increase in net asset value per share. ( 3 The total return equals the change in the ending market value over the beginning of period price per share plus distributions paid per share during the period, divided by the beginning price. ( 4 Annualized. ( 5 Calculated by dividing the lesser of purchases or the sum of ( 1 2

Note 12 - Subsequent Events

Note 12 - Subsequent Events	3 Months Ended
	Mar. 31, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	Note 12. In April 2024, 2023 On April 1, 2024, June 15, 2020, On April 11, 2024, On April 22, 2024,

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	5: Rule 10b5 1 During the fiscal quarter ended December 31, 2023, none 10b5 1 10b5 1
Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of consolidation As required under GAAP and Regulation S- X, Assets related to transactions that do not 860, Transfers and Servicing 2019‑1 2022 1 not
Use of Estimates, Policy [Policy Text Block]	Use of estimates In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments.
Fair Value Measurement, Policy [Policy Text Block]	Fair value The Company records all of its investments at fair value in accordance with relevant GAAP, which establishes a framework used to measure fair value and requires disclosures for fair value measurements. The Company has categorized its investments carried at fair value, based on the priority of the valuation technique, into a three 6. not The availability of observable inputs can vary depending on the financial instrument and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new, whether the product is traded on an active exchange or in the secondary market and the current market conditions. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for financial instruments classified as Level 3. See Note 6
Segment Reporting, Policy [Policy Text Block]	Segments The Company has determined that it has a single reporting segment and operating unit structure. The Company lends to and invests in portfolio companies in various technology, life science, healthcare information and services and sustainability industries. The Company separately evaluates the performance of each of its lending and investment relationships. However, because each of these debt investments and investment relationships has similar business and economic characteristics, they have been aggregated into a single lending and investment segment.
Investment, Policy [Policy Text Block]	Investments Investments are recorded at fair value. Pursuant to the amended SEC Rule 2a 5 1940 July 29, 2022, Interest on debt investments is accrued and included in income based on contractual rates applied to principal amounts outstanding. Interest income is determined using a method that results in a level rate of return on principal amounts outstanding. Generally, when a debt investment becomes 90 not may may March 31, 2024 four December 31, 2023 four three March 31, 2024 2023, not The Company has a limited number of debt investments in its portfolio that contain a PIK provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. For the three March 31, 2024 2023, not three March 31, 2024 one three March 31, 2024 three March 31, 2023, two three March 31, 2023, The Company receives a variety of fees from borrowers in the ordinary course of conducting its business, including advisory fees, commitment fees, amendment fees, non-utilization fees, success fees and prepayment fees. In a limited number of cases, the Company may Certain debt investment agreements also require the borrower to make an ETP, that is accrued into interest receivable and taken into income over the life of the debt investment to the extent such amounts are expected to be collected. The Company will generally cease accruing the income if there is insufficient value to support the accrual or the Company does not not three March 31, 2024 2023 In connection with substantially all lending arrangements, the Company receives warrants to purchase shares of stock from the borrower. The warrants are recorded as assets at estimated fair value on the grant date using the Black-Scholes valuation model. The warrants are considered loan fees and are recorded as unearned income on the grant date. The unearned income is recognized as interest income over the contractual life of the related debt investment in accordance with the Company’s income recognition policy. Subsequent to debt investment origination, the fair value of the warrants is determined using the Black-Scholes valuation model. Any adjustment to fair value is recorded through earnings as net unrealized appreciation or depreciation on investments. Gains and losses from the disposition of the warrants or stock acquired from the exercise of warrants are recognized as realized gains and losses on investments. Realized gains or losses on the sale of investments, or upon the determination that an investment balance, or portion thereof, is not
Debt, Policy [Policy Text Block]	Debt issuance costs Debt issuance costs are fees and other direct incremental costs incurred by the Company in obtaining debt financing from its lenders and issuing debt securities. The unamortized balance of debt issuance costs as of March 31, 2024 December 31, 2023 March 31, 2024 December 31, 2023 three March 31, 2024 2023
Income Tax, Policy [Policy Text Block]	Income taxes As a BDC, the Company has elected to be treated as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to qualify as a RIC and to avoid the imposition of corporate-level income tax on the portion of its taxable income distributed to stockholders, among other things, the Company is required to meet certain source of income and asset diversification requirements and to timely distribute dividends out of assets legally available for distribution to its stockholders of an amount generally at least equal to 90% no 946, Financial Services Investment Companies no Depending on the level of taxable income earned in a tax year, the Company may three March 31, 2024 2023 The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than- not” 740, Income Taxes 946. not not March 31, 2024 December 31, 2023 2024, 2023, 2022 2021
Distributions [Policy Text Block]	Distributions Distributions to common stockholders are recorded on the declaration date. The amount to be paid out as distributions is determined by the Board. Net realized capital gains, if any, may may The Company has adopted a dividend reinvestment plan that provides for reinvestment of cash distributions on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Board declares a cash distribution, then stockholders who have not may
Stockholders' Equity, Policy [Policy Text Block]	Stockholders Equity On August 2, 2021, “2021 2021 may On September 22, 2023, 2021 “2023 2021 2023 may may 415 During the three March 31, 2024 2023 During the three March 31, 2023 2021 The Company generally uses net proceeds from these offerings to make investments, to pay down liabilities and for general corporate purposes. As of March 31, 2024 2023
Stock Repurchase Program [Policy Text Block]	Stock Repurchase Program On April 26, 2024, may, not 10b‑18 1934, 1940 June 30, 2025 $5.0 three March 31, 2024 2023 not March 31, 2024
Transfers and Servicing of Financial Assets, Policy [Policy Text Block]	Transfers of financial assets Assets related to transactions that do not 860, Transfers and Servicing not Transfers of financial assets are accounted for as sales when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when ( 1 2 3 not
New Accounting Pronouncements, Policy [Policy Text Block]	Recently adopted accounting pronouncement In June 2022, No. 2022 03, 2022 03” 2022 03 2022 03 December 15, 2023, 2022 03 not

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments (Unaudited) (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Investment [Table Text Block]	Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Investments — 206.2 Non-Affiliate Debt Investments — 196.6 Non-Affiliate Debt Investments — Life Science — 76.8 Castle Creek Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 $ 5,000 $ 4,982 $ 4,982 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,982 4,982 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,989 2,989 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,982 4,982 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,982 4,982 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,989 2,989 Emalex Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % June 1, 2024 565 564 564 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % June 1, 2024 565 564 564 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % November 1, 2025 5,000 4,957 4,957 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % May 1, 2026 5,000 4,958 4,958 Greenlight Biosciences, Inc. (2)(12) Biotechnology Term Loan 14.25 % Prime 5.75 % 9.00 % - 3.00 % July 1, 2025 2,500 2,429 2,429 Term Loan 14.25 % Prime 5.75 % 9.00 % - 3.00 % July 1, 2025 1,250 1,215 1,215 KSQ Therapeutics, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.50 % May 1, 2027 6,250 6,204 6,204 Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.50 % May 1, 2027 6,250 6,204 6,204 Native Microbials, Inc (2)(12) Biotechnology Term Loan 13.75 % Prime 5.25 % 8.50 % - 5.00 % November 1, 2026 3,750 3,725 3,725 Term Loan 13.75 % Prime 5.25 % 8.50 % - 5.00 % November 1, 2026 2,500 2,484 2,484 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 10,000 9,924 9,924 Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 3,750 3,722 3,722 Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 3,750 3,722 3,722 Provivi, Inc. (2)(12) Biotechnology Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 4,667 4,603 4,327 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 4,667 4,603 4,327 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 2,333 2,295 2,158 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 2,333 2,295 2,158 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 2,333 2,293 2,156 Term Loan 13.86 % Prime 5.36 % 9.50 % - 5.50 % December 1, 2024 2,333 2,293 2,156 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % October 1, 2025 3,643 3,594 3,594 Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % October 1, 2025 1,821 1,797 1,797 Tallac Therapeutics, Inc. (2)(12) Biotechnology Term Loan 12.75 % Prime 4.25 % 12.25 % - 4.00 % August 1, 2027 2,500 2,232 2,232 Term Loan 12.75 % Prime 4.25 % 12.25 % - 4.00 % August 1, 2027 2,500 2,462 2,462 Aerobiotix, LLC (2)(12) Medical Device Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 2,500 2,471 2,339 Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 2,500 2,471 2,339 Term Loan 9.00 % Fixed - - - 18.00 % June 30, 2024 200 200 189 Candesant Biomedical, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 5,000 4,764 4,764 Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 2,500 2,457 2,457 Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 2,500 2,457 2,457 Ceribell, Inc. (2)(12) Medical Device Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 5,000 4,811 4,811 Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 5,000 4,932 4,932 Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 4,000 3,946 3,946 Cognoa, Inc. (2)(12) Medical Device Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % August 1, 2026 4,375 4,332 4,332 Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % August 1, 2026 2,188 2,166 2,166 Conventus Orthopaedics, Inc. (2)(12) Medical Device Term Loan 13.32 % Prime 4.82 % 9.25 % - 10.36 % July 1, 2025 3,911 3,864 3,864 Term Loan 13.32 % Prime 4.82 % 9.25 % - 10.36 % July 1, 2025 3,911 3,864 3,864 CSA Medical, Inc. (2)(12) Medical Device Term Loan 13.59 % Prime 5.09 % 10.00 % - 5.00 % January 1, 2024 391 391 391 Term Loan 13.59 % Prime 5.09 % 10.00 % - 5.00 % March 1, 2024 533 533 533 MicroTransponder, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % - 3.50 % January 1, 2029 3,750 3,691 3,691 Term Loan 12.25 % Prime 3.75 % 12.25 % - 3.50 % January 1, 2029 3,750 3,691 3,691 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Scientia Vascular, Inc. (2)(12) Medical Device Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.00 % January 1, 2027 3,750 3,726 3,726 Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.00 % January 1, 2027 3,750 3,725 3,725 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % January 1, 2027 5,000 4,949 4,949 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % January 1, 2027 5,000 4,909 4,909 Sonex Health, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 2,500 2,475 2,475 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 2,500 2,475 2,475 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 5,000 4,950 4,950 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 5,000 4,950 4,950 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,706 3,706 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,706 3,706 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,706 3,706 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,706 3,706 Spineology, Inc. (2)(12) Medical Device Term Loan 15.50 % Prime 7.00 % 10.25 % - 1.00 % October 1, 2025 5,000 4,981 4,981 Term Loan 15.50 % Prime 7.00 % 10.25 % - 1.00 % April 1, 2026 2,500 2,491 2,491 Swift Health Systems Inc. (2)(12) Medical Device Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,470 3,470 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,470 3,470 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,459 3,459 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,459 3,459 Vero Biotech, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 15,000 14,690 14,690 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 10,000 9,793 9,793 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 5,000 4,897 4,897 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 2,500 2,449 2,449 Total Non-Affiliate Debt Investments — Life Science 256,228 254,853 Non-Affiliate Debt Investments — Sustainability — 21.2 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 4.33 % December 1, 2026 3,750 3,695 3,695 Term Loan 15.25 % Prime 6.75 % 10.00 % - 4.33 % December 1, 2026 3,750 3,695 3,695 Nexii Building Solutions, Inc. (2)(12)(13)(14)(18) Other Sustainability Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,759 8,431 2,477 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,759 8,229 2,418 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,759 8,229 2,418 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 5,840 5,480 1,610 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 5,840 5,480 1,610 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 764 726 213 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 609 578 170 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 304 288 85 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 301 286 84 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 181 172 50 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 833 791 232 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 1,134 1,083 318 Term Loan 15.50 % (11) Fixed - - - - April 30, 2024 418 397 117 Term Loan 15.50 % (11) Fixed - - - - April 30, 2024 552 502 147 Term Loan 15.50 % (11) Fixed - - - - April 30, 2024 411 405 119 Term Loan 15.50 % (11) Fixed - - - - April 30, 2024 487 486 143 Soli Organic, Inc. (2)(12) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % April 1, 2026 5,000 4,967 4,967 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % April 1, 2026 2,500 2,483 2,483 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % May 1, 2026 5,000 4,964 4,964 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % May 1, 2026 2,500 2,482 2,482 Term Loan 14.00 % Prime 5.50 % 11.75 % - 2.75 % December 1, 2026 5,000 4,942 4,942 Term Loan 14.00 % Prime 5.50 % 11.75 % - 2.75 % December 1, 2026 2,500 2,471 2,471 Temperpack Technologies, Inc. (2)(12) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,697 3,697 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,697 3,697 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 7,500 7,386 7,386 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,693 3,693 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,693 3,693 Term Loan 14.50 % Prime 6.00 % 10.00 % - 2.00 % January 1, 2029 4,500 4,448 4,448 Term Loan 14.50 % Prime 6.00 % 10.00 % - 2.00 % January 1, 2029 2,000 1,977 1,977 Total Non-Affiliate Debt Investments — Sustainability 99,853 70,501 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Debt Investments — Technology — 77.6 Axiom Space, Inc. (2)(12) Communications Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,625 5,597 5,597 Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,625 5,597 5,597 Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,625 5,597 5,597 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Term Loan 15.75 % Prime 7.25 % 10.50 % - 3.00 % May 1, 2026 3,033 3,009 3,009 Clara Foods Co. (2)(12) Consumer-related Technologies Term Loan 14.25 % Prime 5.75 % 9.00 % - 5.50 % August 1, 2025 1,417 1,408 1,408 Term Loan 14.25 % Prime 5.75 % 9.00 % - 5.50 % August 1, 2025 1,417 1,408 1,408 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 3,750 3,729 3,729 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 1,250 1,243 1,243 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 3,750 3,729 3,729 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 1,250 1,243 1,243 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 3,750 3,729 3,729 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2027 1,250 1,243 1,243 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % January 1, 2028 3,750 3,716 3,716 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % January 1, 2028 3,750 3,716 3,716 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % April 1, 2028 3,750 3,708 3,708 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2028 3,750 3,709 3,709 Term Loan 11.25 % Prime 6.00 % 9.50 % 11.25 % 3.00 % July 1, 2028 3,750 3,709 3,709 Havenly, Inc. (2)(12) Consumer-related Technologies Term Loan 13.50 % Prime 5.00 % 5.00 % - 4.00 % March 1, 2027 2,000 1,505 1,505 Term Loan 13.50 % Prime 5.00 % 5.00 % - 4.00 % March 1, 2027 3,000 2,258 2,258 Term Loan 12.00 % Prime 3.50 % 10.50 % - 7.78 % February 1, 2028 2,813 2,813 2,813 Term Loan 12.00 % Prime 3.50 % 10.50 % - 7.78 % February 1, 2028 2,813 2,813 2,813 Lyrical Foods, Inc. (2)(12) Consumer-related Technologies Term Loan 12.00 % Prime 3.50 % 9.00 % - 1.00 % September 1, 2027 2,500 2,590 2,435 MyForest Foods Co. (2)(12) Consumer-related Technologies Term Loan 15.25 % Prime 6.75 % 10.00 % - 3.00 % October 1, 2025 3,000 2,986 2,986 Term Loan 15.25 % Prime 6.75 % 10.00 % - 3.00 % October 1, 2025 1,500 1,493 1,493 NextCar Holding Company, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 5,744 5,744 5,014 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,298 2,298 2,006 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,872 2,872 2,507 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 3,446 3,446 3,009 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,872 2,872 2,507 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,872 2,872 2,507 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 5,744 5,744 5,014 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,872 2,872 2,507 Optoro, Inc. (2)(12) Consumer-related Technologies Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % August 1, 2027 2,500 2,424 2,424 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % July 1, 2028 1,875 1,791 1,791 Unagi, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 1,254 1,086 570 Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 627 543 285 Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 627 543 285 Liqid, Inc. (2)(12) Networking Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 833 822 822 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 833 822 822 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 417 410 410 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 417 410 410 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 417 403 403 BriteCore Holdings, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 5,000 4,899 4,899 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,467 2,467 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,467 2,467 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,467 2,467 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % April 1, 2029 2,500 2,464 2,464 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Dropoff, Inc. (2)(12) Software Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % April 1, 2026 6,701 6,607 6,303 Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % April 1, 2026 6,185 6,098 5,819 Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % August 1, 2026 2,577 2,541 2,425 Kodiak Robotics, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 10,000 9,912 9,540 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 10,000 9,912 9,540 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 5,000 4,956 4,770 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 5,000 4,956 4,770 Lemongrass Holdings, Inc. (2)(12) Software Term Loan 15.00 % Prime 6.50 % 9.75 % - 2.50 % March 1, 2026 5,000 4,977 4,977 Term Loan 15.00 % Prime 6.50 % 9.75 % - 2.50 % March 1, 2026 2,500 2,489 2,489 Lytics, Inc. (2)(12) Software Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % November 1, 2026 2,500 2,473 2,473 Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % December 1, 2026 1,250 1,239 1,239 Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % April 1, 2027 1,000 994 994 Mirantis, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,783 4,783 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,919 4,919 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,919 4,919 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,919 4,919 Noodle Partners, Inc. (2)(12) Software Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 10,000 9,896 9,896 Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 5,000 4,947 4,947 Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 5,000 4,947 4,947 Reputation Institute, Inc. (2)(12) Software Term Loan 15.75 % Prime 7.25 % 10.50 % - 3.00 % August 1, 2025 3,233 3,182 3,182 Slingshot Aerospace, Inc. (2)(12) Software Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,965 4,965 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,965 4,965 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,965 4,965 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,965 4,965 Supply Network Visibility Holdings LLC (2)(12) Software Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 2,500 2,458 2,458 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 3,500 3,490 3,490 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 2,500 2,493 2,493 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 1,500 1,496 1,496 Viken Detection Corporation (2)(12) Software Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 5,000 4,779 4,779 Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 2,500 2,470 2,470 Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 2,500 2,470 2,470 Total Non-Affiliate Debt Investments — Technology 264,468 257,817 Non-Affiliate Debt Investments — Healthcare information and services — 21.0 Hound Labs inc. (2) (12) Diagnostics Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 2,500 2,487 2,487 Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 2,500 2,487 2,487 Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 5,000 4,973 4,973 Parse Biosciences, Inc. (2)(12) Diagnostics Term Loan 11.75 % Prime 3.25 % 11.50 % - 5.00 % January 1, 2028 5,000 4,639 4,639 Term Loan 11.75 % Prime 3.25 % 11.50 % - 5.00 % January 1, 2028 5,000 4,890 4,890 BrightInsight, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 7,000 6,727 6,727 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 3,500 3,466 3,466 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 3,500 3,466 3,466 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % April 1, 2028 2,750 2,713 2,713 Elligo Health Research, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 10,000 9,666 9,666 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,930 4,930 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,930 4,930 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,930 4,930 SafelyYou, Inc. (2)(12) Software Term Loan 11.75 % Prime 3.25 % 11.00 % - 5.00 % June 1, 2027 5,000 4,654 4,654 Term Loan 11.75 % Prime 3.25 % 11.00 % - 5.00 % June 1, 2027 5,000 4,924 4,924 Total Non-Affiliate Debt Investments — Healthcare information and services 69,882 69,882 Total Non- Affiliate Debt Investments 690,431 653,053 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrant Investments — 7.2 Non-Affiliate Warrants — Life Science — 2.0 Avalo Therapeutics, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 117 311 — Castle Creek Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 7,404 214 220 Emalex Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 110,402 176 135 Imunon, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 19,671 65 — KSQ Therapeutics, Inc. (2) (12) Biotechnology Preferred Stock Warrant 48,076 50 54 Mustang Bio, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 16,611 146 — Native Microbials, Inc (2)(12) Biotechnology Preferred Stock Warrant 103,679 64 80 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Common Stock Warrant 299,848 160 364 Provivi, Inc. (2)(12) Biotechnology Common Stock Warrant 175,098 278 — Provivi, Inc. (2)(12) Biotechnology Preferred Stock Warrant 691,895 312 232 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Common Stock Warrant 318,181 264 116 Tallac Therapeutics, Inc. (2)(12) Biotechnology Preferred Stock Warrant 1,600,002 194 175 Xeris Pharmaceuticals, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 126,000 72 26 AccuVein Inc. (2)(12) Medical Device Common Stock Warrant 271 7 — Aerin Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 1,818,183 66 1,046 Aerobiotix, LLC (2)(12) Medical Device Preferred Stock Warrant 8,800 48 10 Canary Medical Inc. (2)(12) Medical Device Preferred Stock Warrant 12,153 86 1,299 Candesant Biomedical, Inc. (2)(12) Medical Device Preferred Stock Warrant 93,336 152 138 Ceribell, Inc. (2)(12) Medical Device Preferred Stock Warrant 219,866 139 267 Cognoa, Inc. (2)(12) Medical Device Common Stock Warrant 30,585 — — Cognoa, Inc. (2)(12) Medical Device Preferred Stock Warrant 4,635,992 162 182 Conventus Orthopaedics, Inc. (2)(12) Medical Device Preferred Stock Warrant 9,313,541 256 247 CSA Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 3,341,376 174 128 CVRx, Inc. (2)(5)(12) Medical Device Common Stock Warrant 47,410 76 382 Infobionic, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,010,424 124 50 Magnolia Medical Technologies, Inc. (2)(12) Medical Device Preferred Stock Warrant 809,931 195 374 Meditrina, Inc. (2)(12) Medical Device Preferred Stock Warrant 233,993 83 54 MicroTransponder, Inc. (2)(12) Medical Device Preferred Stock Warrant 103,172 47 48 Scientia Vascular, Inc (2)(12) Medical Device Preferred Stock Warrant 34,410 103 329 Sonex Health, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,637,041 275 276 VERO Biotech LLC (2)(12) Medical Device Preferred Stock Warrant 4,109 432 368 Swift Health Systems Inc. (2)(12) Medical Device Preferred Stock Warrant 135,484 71 2 Total Non-Affiliate Warrants — Life Science 4,802 6,602 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrants — Sustainability — 0.2 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Preferred Stock Warrant 400,000 81 74 LiquiGlide, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 61,359 39 51 Nexii Building Solutions, Inc. (2)(12)(14)(18) Other Sustainability Common Stock Warrant 215,171 490 — Soli Organic, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 681 216 350 Temperpack Technologies, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 46,311 175 84 Total Non-Affiliate Warrants — Sustainability 1,001 559 Non-Affiliate Warrants — Technology — 4.6 Axiom Space, Inc. (2)(12) Communications Common Stock Warrant 1,991 46 62 Intelepeer Holdings, Inc. (2)(12) Communications Preferred Stock Warrant 2,936,535 137 2,894 PebblePost, Inc. (2)(12) Communications Preferred Stock Warrant 598,850 92 132 Alula Holdings, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 20,000 93 3 Aterian, Inc. (2)(5)(12) Consumer-related Technologies Common Stock Warrant 6,140 195 — Caastle, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 268,591 68 2,167 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 75,997 22 28 Clara Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 46,745 30 124 CZV, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 65,569 81 73 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 37,282 95 259 Havenly, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 1,312,500 2,947 2,260 MyForest Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 250 29 58 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 12,618 188 — NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 1,224,752 9 — Optoro, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 11,550 179 145 Primary Kids, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 553,778 57 593 Quip NYC Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 6,191 325 232 Unagi, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 171,081 32 — Updater, Inc.(2)(12) Consumer-related Technologies Preferred Stock Warrant 114,659 34 — CPG Beyond, Inc. (2)(12) Data Storage Preferred Stock Warrant 500,000 241 298 Silk, Inc. (2)(12) Data Storage Preferred Stock Warrant 394,110 175 128 Global Worldwide LLC (2)(12) Internet and Media Preferred Stock Warrant 245,810 74 63 Rocket Lawyer Incorporated (2)(12) Internet and Media Preferred Stock Warrant 261,721 92 323 Skillshare, Inc. (2)(12) Internet and Media Preferred Stock Warrant 139,074 162 1,206 Liqid, Inc. (2)(12) Networking Preferred Stock Warrant 344,102 364 224 Halio, Inc. (2)(12) Power Management Common Stock Warrant 38,241,466 1,585 2,700 Avalanche Technology, Inc. (2)(12) Semiconductors Preferred Stock Warrant 5,938 45 — BriteCore Holdings, Inc. (2)(12) Software Preferred Stock Warrant 161,215 98 136 Dropoff, Inc. (2)(12) Software Common Stock Warrant 516,732 455 56 E La Carte, Inc. (2)(5)(12) Software Common Stock Warrant 147,361 60 — Everstream Holdings, LLC (2)(12) Software Preferred Stock Warrant 350,000 70 63 Kodiak Robotics, Inc. (2)(12) Software Preferred Stock Warrant 639,918 273 11 Lemongrass Holdings, Inc. (2)(12) Software Preferred Stock Warrant 101,308 34 121 Lotame Solutions, Inc. (2)(12) Software Preferred Stock Warrant 71,305 18 42 Lytics, Inc. (2)(12) Software Preferred Stock Warrant 85,543 43 — Mirantis, Inc. (2)(12) Software Common Stock Warrant 948,275 220 253 Noodle Partners, Inc. (2)(12) Software Preferred Stock Warrant 84,037 116 3 Reputation Institute, Inc. (2)(12) Software Preferred Stock Warrant 4,104 66 83 Revinate Holdings, Inc. (2)(12) Software Preferred Stock Warrant 682,034 44 93 SIGNiX, Inc. (12) Software Preferred Stock Warrant 186,235 225 — Slingshot Aerospace, Inc. (2)(12) Software Preferred Stock Warrant 309,208 123 85 Supply Network Visibility Holdings LLC (2)(12) Software Preferred Stock Warrant 682 64 138 Topia Mobility, Inc. (2)(12) Software Preferred Stock Warrant 3,049,607 138 — Viken Detection Corporation (2)(12) Software Preferred Stock Warrant 345,443 120 211 xAd, Inc. (2)(12) Software Preferred Stock Warrant 4,343,348 177 8 Total Non-Affiliate Warrants — Technology 9,741 15,275 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrants — Healthcare information and services — 0.4 Hound Labs, Inc (2)(12) Diagnostics Preferred Stock Warrant 171,370 47 12 Parse Biosciences, Inc. (2)(12) Diagnostics Common Stock Warrant 32,244 70 70 Parse Biosciences, Inc. (2)(12) Diagnostics Preferred Stock Warrant 184,253 166 171 Kate Farms, Inc. (2)(12) Other Healthcare Preferred Stock Warrant 82,965 102 949 BrightInsight, Inc. (2)(12) Software Preferred Stock Warrant 85,066 168 — Elligo Health Research, Inc. (2)(12) Software Preferred Stock Warrant 652,250 191 98 Medsphere Systems Corporation (2)(12) Software Preferred Stock Warrant 7,097,792 60 134 SafelyYou, Inc. (2)(12) Software Preferred Stock Warrant 150,353 163 58 Total Non-Affiliate Warrants — Healthcare information and services 967 1,492 Total Non-Affiliate Warrants 16,511 23,928 Non-Affiliate Other Investments — Life Science — 1.0 Lumithera, Inc. (12) Medical Device Royalty Agreement 1,200 100 Robin Healthcare, Inc. (2)(12) Medical Device Royalty Agreement 7,181 3,247 ZetrOZ, Inc. (12) Medical Device Royalty Agreement — — Total Non-Affiliate Other Investments 8,381 3,347 Non-Affiliate Equity — 1.4 Cadrenal Therapeutics, Inc. (5) Biotechnology Common Stock 600,000 — 367 Castle Creek Biosciences, Inc. (12) Biotechnology Common Stock 1,162 250 250 Emalex Biosciences, Inc. (12) Biotechnology Common Stock 32,831 355 355 Axiom Space, Inc. (12) Communications Preferred Stock 1,810 261 306 Getaround, Inc. (2)(5) Consumer-related Technologies Common Stock 87,082 253 27 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock 2,688,971 89 — SnagAJob.com, Inc. (12) Consumer-related Technologies Common Stock 82,974 10 80 Lumithera, Inc. (12) Medical Device Common Stock 392,651 2,000 1,700 Tigo Energy, Inc. (5) Other Sustainability Common Stock 5,205 111 8 Decisyon, Inc. (12) Software Preferred Stock 280,000 2,800 1,281 Lotame, Inc. (12) Software Preferred Stock 66,127 4 193 Total Non-Affiliate Equity 6,133 4,567 Total Non-Affiliate Portfolio Investment Assets $ 721,456 $ 684,895 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Controlled Affiliate Investments — 3.8 Non-Controlled Affiliate Debt Investments — Life Sciences — 3.8 Evelo Biosciences, Inc. (2)(5)(12)(13) Biotechnology Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 5,712 5,228 2,790 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 8,568 7,880 4,207 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 3,427 3,137 1,674 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 3,427 3,137 1,674 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 2,285 2,091 1,116 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 2,285 2,091 1,116 Total Non-Controlled Affiliate Debt Investments 23,564 12,577 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-controlled Affiliate Equity — Life Sciences — 0.0 Aulea Medical, Inc. (12)(16) Medical Device Common Stock 660,537 — — Evelo Biosciences, Inc. (5)(12) Biotechnology Common Stock 2,164,502 5,000 — Total Non-Controlled Affiliate Equity 5,000 — Non-controlled Affiliate Warrants — Life Sciences — 0.0 Evelo Biosciences, Inc. (2)(5)(12) Biotechnology Common Stock 23,196 125 — Total Non-Controlled Affiliate Warrants 125 — Total Non-Controlled Affiliate Portfolio Investment Assets $ 28,689 $ 12,577 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Controlled Affiliate Investments — 4.1 Controlled Affiliate Debt Investments — Technology — 1.5 Better Place Forests Co. (12) Consumer-related Technologies Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - 2.78 % August 1, 2029 3,658 3,698 3,455 Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - 2.78 % August 1, 2029 1,829 1,807 1,688 Total Controlled Affiliate Debt Investments 5,505 5,143 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Controlled Affiliate Equity — Technology — 0.8 Better Place Forests Co. (12) Consumer-related Technologies Common Stock 2,278,272 2,060 659 Better Place Forests Co. (12) Consumer-related Technologies Preferred Stock 4,458,452 2,000 1,997 Total Controlled Affiliate Equity 4,060 2,656 Controlled Affiliate Other Investments — Life Sciences — 1.8 HIMV LLC (12)(17) Biotechnology Other Investment 5,463 5,845 Total Controlled Affiliate Other 5,463 5,845 Total Controlled Affiliate Portfolio Investment Assets $ 15,028 $ 13,644 Total Portfolio Investment Assets — 214.1 $ 765,173 $ 711,116 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Investments — 214.2 Non-Affiliate Debt Investments — 205.0 Non-Affiliate Debt Investments — Life Science — 75.6 Castle Creek Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 $ 5,000 $ 4,979 $ 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,979 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,987 2,987 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,979 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,979 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,987 2,987 Emalex Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % June 1, 2024 1,414 1,410 1,410 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % June 1, 2024 1,414 1,410 1,410 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % November 1,

Note 4 - Investments (Tables)

Note 4 - Investments (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Investment Holdings, Schedule of Investments [Table Text Block]	March 31, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Investments Debt $ 719,500 $ 670,773 $ 721,231 $ 670,172 Warrants 16,636 23,928 16,526 24,594 Other 13,844 9,192 6,982 6,430 Equity 15,193 7,223 14,443 7,889 Total investments $ 765,173 $ 711,116 $ 759,182 $ 709,085 March 31, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Life Science Biotechnology $ 142,108 $ 124,741 $ 145,544 $ 117,781 Medical Device 164,060 161,155 147,064 145,019 Technology Communications 17,327 20,185 19,192 22,188 Consumer-Related 105,165 99,876 105,669 101,327 Data Storage 416 426 417 418 Internet and Media 328 1,592 329 1,582 Networking 3,231 3,091 5,451 5,297 Power Management 1,585 2,700 1,585 2,700 Semiconductors 45 — 45 — Software 159,094 154,908 164,133 160,749 Sustainability Energy Efficiency 111 8 111 13 Other Sustainability 100,854 71,060 98,906 80,370 Healthcare Information and Services Diagnostics 19,759 19,729 19,735 19,701 Other 102 949 102 1,366 Software 50,988 50,696 50,899 50,574 Total investments $ 765,173 $ 711,116 $ 759,182 $ 709,085

Note 5 - Transactions With Af_2

Note 5 - Transactions With Affiliated Companies (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Investments in and Advances to Affiliates [Table Text Block]	Three months ended March 31, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized March 31, Interest Company 2023 Purchases Payments fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Aulea Medical, Inc. $ — $ 3 $ — $ — $ — $ — $ (3 ) $ — $ — Evelo Biosciences, Inc. 222 — — — — 2,568 — 2,790 — 336 12 — — — 3,859 — 4,207 — 133 — — — — 1,541 — 1,674 — 133 — — — — 1,541 — 1,674 — 88 — — — — 1,028 — 1,116 — 88 — — — — 1,028 — 1,116 — 132 — — — — (132 ) — — — Total non-controlled affiliates $ 1,132 $ 15 $ — $ — $ — $ 11,433 $ (3 ) $ 12,577 $ — Three months ended March 31, 2023 Fair value at Transfers Net Fair value at Portfolio December 31, in/(out) at Discount unrealized Net realized March 31, Interest Company 2022 Purchases Sales fair value Accretion gain/(loss) gain/(loss) 2023 income (In thousands) Cadrenal Therapeutics, Inc. — — — — — 846 — 846 — Total non-controlled affiliates $ — $ — $ — $ — $ — $ 846 $ — $ 846 $ — Three months ended March 31, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized March 31, Interest Company 2023 Purchases Payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,339 $ — $ — $ 111 $ — $ 2 $ 3 $ — $ 3,455 $ 116 1,630 — — 55 — 2 1 — 1,688 61 3,024 750 — — — — (1,118 ) — 2,656 — HIMV LLC 6,230 227 (547 ) — — — (65 ) — 5,845 — Total controlled affiliates $ 14,223 $ 977 $ (547 ) $ 166 $ — $ 4 $ (1,179 ) $ — $ 13,644 $ 177

Note 6 - Fair Value (Tables)

Note 6 - Fair Value (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	March 31, 2024 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 670,773 $ 670,773 Warrant investments — 772 23,156 23,928 Other investments — — 9,192 9,192 Equity investments 398 — 6,825 7,223 Total investments $ 398 $ 772 $ 709,946 $ 711,116 December 31, 2023 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 670,172 $ 670,172 Warrant investments — 1,619 22,975 24,594 Other investments — — 6,430 6,430 Equity investments 608 — 7,281 7,889 Total investments $ 608 $ 1,619 $ 706,858 $ 709,085
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	March 31, 2024 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 619,773 Discounted Expected Future Cash Flows Hypothetical Market Yield 11% – 20% 15 % 51,000 Multiple Probability Weighted Cash Flow Model Probability Weighting 5% - 95% 44 % Warrant investments 23,094 Black-Scholes Valuation Model Price Per Share 0.000 –1,898.58 $ 61.04 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 18 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 9,192 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 75 % Equity investments 6,825 Last Equity Financing Price Per Share 0.00 215.03 $ 18.21 Total Level 3 investments $ 709,946 December 31, 2023 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 617,529 Discounted Expected Future Cash Flows Hypothetical Market Yield 11% – 24% 15 % 52,643 Multiple Probability Weighted Cash Flow Model Probability Weighting 20% - 100% 50 % Warrant investments 22,913 Black-Scholes Valuation Model Price Per Share 0.000 –1,899 $ 64.95 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 18 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 6,430 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 81 % Equity investments 7,281 Last Equity Financing Price Per Share 0.56 215.03 $ 17.15 Total Level 3 investments $ 706,858
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Three months ended March 31, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 670,172 $ 22,975 $ 7,281 $ 6,430 $ 706,858 Purchase of investments 22,177 — 750 392 23,319 Warrants received and classified as Level 3 — 128 — — 128 Principal payments received on investments (19,080 ) — — (563 ) (19,643 ) Payment-in-kind interest on investments 1,382 — — — 1,382 Proceeds from sale of investments (41 ) — — — (41 ) Net realized gain (loss) on investments 38 (17 ) — — 21 Unrealized (depreciation) appreciation included in earnings (1,509 ) 70 (1,206 ) (258 ) (2,903 ) Transfer out of debt investments (3,191 ) — — 3,191 — Other 825 — — — 825 Level 3 assets, end of period $ 670,773 $ 23,156 $ 6,825 $ 9,192 $ 709,946 Three months ended March 31, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 686,458 $ 26,145 $ 2,416 $ 1,300 $ 716,319 Purchase of investments 46,998 — 10 — 47,008 Warrants received and classified as Level 3 — 141 — — 141 Principal payments received on investments (39,756 ) — — — (39,756 ) Payment-in-kind interest on investments 1,204 — — — 1,204 Proceeds from sale of investments (6,508 ) (12 ) — — (6,520 ) Net realized gain (loss) on investments 7 (141 ) — — (134 ) Unrealized (depreciation) appreciation included in earnings (4,566 ) (1,490 ) 189 — (5,867 ) Transfer out of debt investments (295 ) (5 ) 300 — — Other 1,012 — — — 1,012 Level 3 assets, end of period $ 684,554 $ 24,638 $ 2,915 $ 1,300 $ 713,407

Note 7 - Borrowings (Tables)

Note 7 - Borrowings (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Debt [Table Text Block]	March 31, 2024 December 31, 2023 Total Balance Unused Total Balance Unused Commitment Outstanding Commitment Commitment Outstanding Commitment (In thousands) Key Facility $ 150,000 $ 60,000 $ 90,000 $ 150,000 $ 70,000 $ 80,000 NYL Facility 250,000 181,000 69,000 250,000 181,000 69,000 2022 Asset-Backed Notes 100,000 100,000 — 100,000 100,000 — 2027 Notes 57,500 57,500 — 57,500 57,500 — 2026 Notes 57,500 57,500 — 57,500 57,500 — Total before debt issuance costs 615,000 456,000 159,000 615,000 466,000 149,000 Unamortized debt issuance costs attributable to term borrowings — (3,510 ) — — (3,765 ) — Total borrowings outstanding, net $ 615,000 $ 452,490 $ 159,000 $ 615,000 $ 462,235 $ 149,000

Note 8 - Financial Instrument_2

Note 8 - Financial Instruments With Off-balance-sheet Risk (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Schedule of Fair Value, off-Balance-Sheet Risks [Table Text Block]	March 31, 2024 December 31, 2023 Fair Value of Fair Value of Unfunded Unfunded Commitment Commitment Commitment Commitment Amount Liability Amount Liability (In thousands) (In thousands) BrightInsight, Inc. $ 15,500 $ 205 $ 15,500 $ 241 Britecore Holdings, Inc. 2,500 36 5,000 72 Candesant Biomedical Corporation 10,000 151 10,000 151 Ceribell, Inc. 21,000 120 — — Divergent Technologies, Inc. — — 11,250 118 Elligo Healthcare Research, Inc. 15,000 194 15,000 194 MicroTransponder, Inc. 22,500 — 22,500 — Mirantis, Inc. 15,000 136 15,000 136 Nexii Building Solutions, Inc. 486 — — — Optoro, Inc. 6,250 — 6,250 — Parse Biosciences, Inc. 15,000 251 15,000 251 SafelyYou, Inc. 20,000 270 20,000 270 Sonex Health, Inc. — — 15,000 176 Supply Network Visibility Holdings, LLC 10,000 35 10,000 35 Tallac Therapeutics, Inc. 5,000 229 10,000 229 Viken Detection Corporation 10,000 160 10,000 160 Total $ 168,236 $ 1,787 $ 180,500 $ 2,033

Note 10 - Distributions (Tables

Note 10 - Distributions (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Dividends Declared [Table Text Block]	DRIP DRIP Date Amount Cash Shares Share Declared Record Date Payment Date Per Share Distribution Issued Value (In thousands, except share and per share data) Three Months Ended March 31, 2024 2/23/2024 5/17/2024 6/14/2024 $ 0.11 $ — — $ — 2/23/2024 4/18/2024 5/15/2024 0.11 — — — 2/23/2024 3/19/2024 4/16/2024 0.05 1,625 7,598 85 2/23/2024 3/19/2024 4/16/2024 0.11 3,574 16,717 188 $ 0.38 $ 5,199 24,315 $ 273 Year Ended December 31, 2023 10/27/2023 2/16/2024 3/15/2024 $ 0.11 $ 3,463 18,257 $ 210 10/27/2023 1/18/2024 2/14/2024 0.11 3,462 15,873 210 10/27/2023 12/19/2023 1/16/2024 0.11 3,472 14,563 199 10/27/2023 11/17/2023 12/15/2023 0.05 1,574 7,137 93 7/28/2023 11/17/2023 12/15/2023 0.11 3,463 15,701 206 7/28/2023 10/18/2023 11/15/2023 0.11 3,493 14,022 173 7/28/2023 9/19/2023 10/16/2023 0.11 3,445 15,067 184 4/28/2023 8/17/2023 9/15/2023 0.11 3,458 8,665 106 4/28/2023 7/18/2023 8/15/2023 0.11 3,427 8,307 105 4/28/2023 6/16/2023 7/14/2023 0.11 3,434 7,424 96 2/23/2023 5/18/2023 6/14/2023 0.11 3,087 7,128 86 2/23/2023 4/18/2023 5/16/2023 0.11 3,068 6,705 84 2/23/2023 3/17/2023 4/14/2023 0.11 3,035 6,894 81 $ 1.37 $ 41,881 145,743 $ 1,833 Ex-Dividend Date Record Date Payment Date Distributions Declared August 16, 2024 August 16, 2024 September 13, 2024 $ 0.11 July 17, 2024 July 17, 2024 August 15, 2024 $ 0.11 June 17, 2024 June 17, 2024 July 16, 2024 $ 0.11

Note 11 - Financial Highlights

Note 11 - Financial Highlights (Tables)	3 Months Ended
	Mar. 31, 2024
Notes Tables
Investment Company, Financial Highlights [Table Text Block]	Three months ended March 31, 2024 2023 (In thousands, except share and per share data) Per share data: Net asset value at beginning of period $ 9.71 $ 11.47 Net investment income 0.38 0.46 Realized loss — (0.01 ) Unrealized depreciation on investments (0.12 ) (0.26 ) Net increase in net assets resulting from operations 0.26 0.19 Distributions declared (1) (0.38 ) (0.33 ) From net investment income (0.38 ) (0.33 ) From net realized gain on investments — — Return of capital — — Other (2) 0.05 0.01 Net asset value at end of period $ 9.64 $ 11.34 Per share market value, beginning of period $ 13.17 $ 11.60 Per share market value, end of period $ 11.37 $ 11.28 Total return based on a market value (3) (11.2 )% 0.1 % Shares outstanding at end of period 34,469,878 28,377,357 Ratios to average net assets: Expenses without incentive fee (4) 15.7 % 14.8 % Incentive fees (4) 0.4 % 3.7 % Net expenses (4) 16.1 % 18.5 % Net investment income with incentive fee (4) 15.4 % 16.3 % Net assets at the end of the period $ 332,121 $ 321,683 Average net asset value $ 328,051 $ 320,066 Average debt per share $ 13.61 $ 15.61 Portfolio turnover ratio 1.4 % (5) 4.2 % (5)

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments (Unaudited) (Details Textual) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023	Jul. 31, 2023	Nov. 09, 2022
Debt Instrument, Face Amount	$ 615	$ 615
Percentage of Nonqualifying Assets on a Cost Basis	4.90%	4.70%
Percentage of Nonqualifying Assets on a Fair Value Basis	1.50%	2.70%
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member]
Investment, Interest Rate, Paid in Kind	4.50%	4.50%
Investment, Affiliated Issuer, Noncontrolled [Member] | Medical Device Sector [Member] | Aulea Medical Inc 1[Member]
Investment Owned, Balance, Shares (in shares)			660,537
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Co-lender [Member]
Investment Owned, Net Assets, Percentage		30%
Horizon Technology Finance Corporation [Member] | Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investment Owned, Net Assets, Percentage	70%	70%
Asset-backed Notes 2022 [Member]
Debt Instrument, Face Amount	$ 100	$ 100		$ 157.8
Asset-backed Notes 2022 [Member] | Affiliated Entity [Member]
Debt Instrument, Face Amount				$ 100

Consolidated Schedule of Inve_4

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Investments at cost	$ 765,173	$ 759,182
Investments at fair value	711,116	709,085
Warrant [Member]
Investments at cost	16,636	16,526
Investments at fair value	23,928	24,594
Investment, Unaffiliated Issuer [Member]
Investments at cost	721,456	716,077
Investments at fair value	684,895	693,730
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	690,431	692,345
Investments at fair value	653,053	664,203
Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	16,511	16,400
Investments at fair value	23,928	24,594
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member]
Investments at cost	6,133	6,132
Investments at fair value	4,567	4,733
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost	28,689	28,677
Investments at fair value	12,577	1,132	$ 846	$ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member]
Investments at fair value	12,577
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member]
Investments at cost	125	126
Investments at fair value	0	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member]
Investments at fair value	0	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member]
Investments at fair value			$ 846	$ 0
Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	15,028	14,428
Investments at fair value	13,644	14,223
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investments at fair value	5,845	6,230
Biotechnology Sector [Member]
Investments at cost	142,108	145,544
Investments at fair value	$ 124,741	$ 117,781
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	9.55%	9.55%
Ceiling	13.50%	13.50%
ETP	5.50%	5.50%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,982	4,979
Investments at fair value	$ 4,982	$ 4,979
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	9.55%	9.55%
Ceiling	13.50%	13.50%
ETP	5.50%	5.50%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,982	4,979
Investments at fair value	4,982	4,979
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	214	214
Investments at fair value	$ 220	$ 318
Number of Shares (in shares)	7,404	7,404
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Common Stock [Member]
Investments at cost	$ 250	$ 250
Investments at fair value	$ 250	$ 250
Number of Shares (in shares)	1,162	1,162
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	9.55%	9.55%
Ceiling	13.50%	13.50%
ETP	5.50%	5.50%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 3,000	$ 3,000
Investments at cost	2,989	2,987
Investments at fair value	$ 2,989	$ 2,987
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	9.55%	9.55%
Ceiling	13.50%	13.50%
ETP	5.50%	5.50%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,982	4,979
Investments at fair value	$ 4,982	$ 4,979
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	9.55%	9.55%
Ceiling	13.50%	13.50%
ETP	5.50%	5.50%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,982	4,979
Investments at fair value	$ 4,982	$ 4,979
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	9.55%	9.55%
Ceiling	13.50%	13.50%
ETP	5.50%	5.50%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 3,000	$ 3,000
Investments at cost	2,989	2,987
Investments at fair value	2,989	2,987
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	311	311
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	117	117
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.22%	13.22%
Margin	4.72%	4.72%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jun. 01, 2024	Jun. 01, 2024
Principal Amount	$ 565	$ 1,414
Investments at cost	564	1,410
Investments at fair value	$ 564	$ 1,410
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.22%	13.22%
Margin	4.72%	4.72%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jun. 01, 2024	Jun. 01, 2024
Principal Amount	$ 565	$ 1,414
Investments at cost	564	1,410
Investments at fair value	564	1,410
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	176	178
Investments at fair value	$ 135	$ 246
Number of Shares (in shares)	110,402	110,402
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Common Stock [Member]
Investments at cost	$ 355	$ 355
Investments at fair value	$ 355	$ 355
Number of Shares (in shares)	32,831	32,831
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	13.22%	13.22%
Margin	4.72%	4.72%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Nov. 01, 2025	Nov. 01, 2025
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,957	4,950
Investments at fair value	$ 4,957	$ 4,950
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	13.22%	13.22%
Margin	4.72%	4.72%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,958	4,949
Investments at fair value	4,958	4,949
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Imunon, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	65	65
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	19,671	19,671
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	8.50%	8.50%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	May 01, 2027	May 01, 2027
Principal Amount	$ 6,250	$ 6,250
Investments at cost	6,204	6,199
Investments at fair value	$ 6,204	$ 6,199
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	8.50%	8.50%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	May 01, 2027	May 01, 2027
Principal Amount	$ 6,250	$ 6,250
Investments at cost	6,204	6,199
Investments at fair value	6,204	6,199
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	50	50
Investments at fair value	$ 54	$ 53
Number of Shares (in shares)	48,076	48,076
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mustang Bio, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 146	$ 146
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	16,611	16,611
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.75%	13.75%
Margin	5.25%	5.25%
Floor	8.50%	8.50%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Nov. 01, 2026	Nov. 01, 2026
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,725	3,716
Investments at fair value	$ 3,725	$ 3,716
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.75%	13.75%
Margin	5.25%	5.25%
Floor	8.50%	8.50%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Nov. 01, 2026	Nov. 01, 2026
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,484	2,478
Investments at fair value	2,484	2,478
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	64	64
Investments at fair value	$ 80	$ 157
Number of Shares (in shares)	103,679	103,679
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	3.75%	3.75%
Maturity Date	Sep. 01, 2026	Sep. 01, 2026
Principal Amount	$ 10,000	$ 10,000
Investments at cost	9,924	9,911
Investments at fair value	$ 9,924	$ 9,911
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	3.75%	3.75%
Maturity Date	Sep. 01, 2026	Sep. 01, 2026
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,722	3,717
Investments at fair value	3,722	3,717
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Common Stock Warrants [Member]
Investments at cost	160	160
Investments at fair value	$ 364	$ 606
Number of Shares (in shares)	299,848	299,848
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	3.75%	3.75%
Maturity Date	Sep. 01, 2026	Sep. 01, 2026
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,722	3,717
Investments at fair value	$ 3,722	$ 3,717
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.86%	13.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	Dec. 01, 2024	Dec. 01, 2024
Principal Amount	$ 4,667	$ 4,666
Investments at cost	4,603	4,579
Investments at fair value	$ 4,327	$ 4,414
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.86%	13.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	Dec. 01, 2024	Dec. 01, 2024
Principal Amount	$ 4,667	$ 4,666
Investments at cost	4,603	4,579
Investments at fair value	4,327	4,414
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	278	278
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	175,098	175,098
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 312	$ 312
Investments at fair value	$ 232	$ 225
Number of Shares (in shares)	691,895	691,895
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	13.86%	13.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	Dec. 01, 2024	Dec. 01, 2024
Principal Amount	$ 2,333	$ 2,333
Investments at cost	2,295	2,281
Investments at fair value	$ 2,158	$ 2,199
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	13.86%	13.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	Dec. 01, 2024	Dec. 01, 2024
Principal Amount	$ 2,333	$ 2,333
Investments at cost	2,295	2,281
Investments at fair value	$ 2,158	$ 2,199
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	13.86%	13.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	Dec. 01, 2024	Dec. 01, 2024
Principal Amount	$ 2,333	$ 2,333
Investments at cost	2,293	2,278
Investments at fair value	$ 2,156	$ 2,196
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	13.86%	13.86%
Margin	5.36%	5.36%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	Dec. 01, 2024	Dec. 01, 2024
Principal Amount	$ 2,333	$ 2,333
Investments at cost	2,293	2,278
Investments at fair value	$ 2,156	$ 2,196
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Jul. 01, 2025	Jul. 01, 2025
Principal Amount	$ 2,500	$ 3,000
Investments at cost	2,429	2,914
Investments at fair value	$ 2,429	$ 2,870
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Jul. 01, 2025	Jul. 01, 2025
Principal Amount	$ 1,250	$ 1,500
Investments at cost	1,215	1,458
Investments at fair value	$ 1,215	$ 1,436
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	8.75%	8.75%
Ceiling	0%	0%
ETP	6%	6%
Maturity Date	Oct. 01, 2025	Oct. 01, 2025
Principal Amount	$ 3,643	$ 4,250
Investments at cost	3,594	4,193
Investments at fair value	$ 3,594	$ 4,193
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	8.75%	8.75%
Ceiling	0%	0%
ETP	6%	6%
Maturity Date	Oct. 01, 2025	Oct. 01, 2025
Principal Amount	$ 1,821	$ 2,125
Investments at cost	1,797	2,096
Investments at fair value	1,797	2,096
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	264	264
Investments at fair value	$ 116	$ 113
Number of Shares (in shares)	318,181	318,181
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	12.25%	12.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,232	2,230
Investments at fair value	$ 2,232	$ 2,230
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	12.25%	12.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,462	2,459
Investments at fair value	2,462	2,459
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	194	194
Investments at fair value	$ 175	$ 172
Number of Shares (in shares)	1,600,002	1,600,002
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Xeris Pharmaceuticals, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 72	$ 72
Investments at fair value	$ 26	$ 33
Number of Shares (in shares)	126,000	126,000
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cadrenal Therapeutics, Inc. [Member] | Common Stock [Member]
Investments at cost	$ 0	$ 0
Investments at fair value	$ 367	$ 443
Number of Shares (in shares)	600,000	600,000
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Warrant [Member]
Investments at cost	$ 125	$ 126
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	23,196	23,196
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	11%	11%
Ceiling	0%	0%
ETP	4.25%	2.27%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 5,712	$ 5,532
Investments at cost	5,228	5,228
Investments at fair value	$ 2,790	$ 222
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	11%	11%
Ceiling	0%	0%
ETP	4.25%	2.27%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 8,568	$ 8,298
Investments at cost	7,880	7,867
Investments at fair value	4,207	336
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Common Stock [Member]
Investments at cost	5,000	5,000
Investments at fair value	$ 0	$ 132
Number of Shares (in shares)	2,164,502	2,164,502
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	11%	11%
Ceiling	0%	0%
ETP	4.25%	2.27%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 3,427	$ 3,319
Investments at cost	3,137	3,137
Investments at fair value	$ 1,674	$ 133
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	11%	11%
Ceiling	0%	0%
ETP	4.25%	2.27%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 3,427	$ 3,319
Investments at cost	3,137	3,137
Investments at fair value	$ 1,674	$ 133
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	11%	11%
Ceiling	0%	0%
ETP	4.25%	2.27%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 2,285	$ 2,213
Investments at cost	2,091	2,091
Investments at fair value	$ 1,116	$ 88
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	11%	11%
Ceiling	0%	0%
ETP	4.25%	2.27%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 2,285	$ 2,213
Investments at cost	2,091	2,091
Investments at fair value	1,116	88
Medical Device Sector [Member]
Investments at cost	164,060	147,064
Investments at fair value	$ 161,155	$ 145,019
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	8.50%	8.50%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,726	3,722
Investments at fair value	$ 3,726	$ 3,722
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.25%	13.25%
Margin	4.75%	4.75%
Floor	8.50%	8.50%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,725	3,722
Investments at fair value	3,725	3,722
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	103	103
Investments at fair value	$ 329	$ 215
Number of Shares (in shares)	34,410	34,410
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	13.75%	13.75%
Margin	5.25%	5.25%
Floor	9%	9%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,949	4,943
Investments at fair value	$ 4,949	$ 4,943
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	13.75%	13.75%
Margin	5.25%	5.25%
Floor	9%	9%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jan. 01, 2027	Jan. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,909	4,900
Investments at fair value	4,909	$ 4,900
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14%
Margin		5.50%
Floor		10.25%
Ceiling		0%
ETP		4%
Maturity Date		Nov. 01, 2026
Principal Amount		$ 3,500
Investments at cost		3,469
Investments at fair value		$ 1,574
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14%
Margin		5.50%
Floor		10.25%
Ceiling		0%
ETP		4%
Maturity Date		Nov. 01, 2026
Principal Amount		$ 3,500
Investments at cost		3,563
Investments at fair value		$ 1,617
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Royalty Agreement [Member]
Investments at cost	7,181
Investments at fair value	$ 3,247
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	8%	8%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,475	2,297
Investments at fair value	$ 2,475	$ 2,297
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	8%	8%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,475	2,473
Investments at fair value	2,475	2,473
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	275	275
Investments at fair value	$ 276	$ 269
Number of Shares (in shares)	2,637,041	2,637,043
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	8%	8%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,950	4,946
Investments at fair value	$ 4,950	$ 4,946
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	8%	8%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,950	4,946
Investments at fair value	$ 4,950	$ 4,946
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	12%
Margin	3.50%
Floor	11.75%
Ceiling	0%
ETP	8%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 3,750
Investments at cost	3,706
Investments at fair value	$ 3,706
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	12%
Margin	3.50%
Floor	11.75%
Ceiling	0%
ETP	8%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 3,750
Investments at cost	3,706
Investments at fair value	$ 3,706
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate	12%
Margin	3.50%
Floor	11.75%
Ceiling	0%
ETP	8%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 3,750
Investments at cost	3,706
Investments at fair value	$ 3,706
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate	12%
Margin	3.50%
Floor	11.75%
Ceiling	0%
ETP	8%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 3,750
Investments at cost	3,706
Investments at fair value	$ 3,706
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	1%	1%
Maturity Date	Oct. 01, 2025	Oct. 01, 2025
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,981	4,978
Investments at fair value	$ 4,981	$ 4,978
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	1%	1%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,491	2,489
Investments at fair value	2,491	2,489
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Common Stock [Member]
Investments at cost	2,000	2,000
Investments at fair value	$ 1,700	$ 1,700
Number of Shares (in shares)	392,651	392,651
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Royalty Agreement [Member]
Investments at cost	$ 1,200	$ 1,200
Investments at fair value	$ 100	$ 200
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.75%	13.75%
Margin	5.25%	5.25%
Floor	9%	9%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 3,500	$ 3,500
Investments at cost	3,470	3,467
Investments at fair value	$ 3,470	$ 3,467
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.75%	13.75%
Margin	5.25%	5.25%
Floor	9%	9%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 3,500	$ 3,500
Investments at cost	3,470	3,467
Investments at fair value	3,470	3,467
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	71	71
Investments at fair value	$ 2	$ 1
Number of Shares (in shares)	135,484	135,484
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	13.75%	13.75%
Margin	5.25%	5.25%
Floor	9%	9%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 3,500	$ 3,500
Investments at cost	3,459	3,456
Investments at fair value	$ 3,459	$ 3,456
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	13.75%	13.75%
Margin	5.25%	5.25%
Floor	9%	9%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 3,500	$ 3,500
Investments at cost	3,459	3,456
Investments at fair value	3,459	3,456
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | ZetrOZ, Inc [Member] | Royalty Agreement [Member]
Investments at cost	0	0
Investments at fair value	0	0
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | AccuVein Inc [Member] | Common Stock Warrants [Member]
Investments at cost	7	24
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	271	1,175
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerin Medical, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 66	$ 66
Investments at fair value	$ 1,046	$ 1,199
Number of Shares (in shares)	1,818,183	1,818,183
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 48	$ 48
Investments at fair value	$ 10	$ 9
Number of Shares (in shares)	8,800	8,800
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index One [Member]
Cash Rate	9%	9%
Margin	0%	0%
Floor	0%	0%
Ceiling	0%	0%
ETP	18%	18%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,471	2,468
Investments at fair value	$ 2,339	$ 2,342
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Two [Member]
Cash Rate	9%	9%
Margin	0%	0%
Floor	0%	0%
Ceiling	0%	0%
ETP	18%	18%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,471	2,468
Investments at fair value	$ 2,339	$ 2,342
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Three [Member]
Cash Rate	9%	9%
Margin	0%	0%
Floor	0%	0%
Ceiling	0%	0%
ETP	18%	18%
Maturity Date	Jun. 30, 2024	Jun. 30, 2024
Principal Amount	$ 200	$ 200
Investments at cost	200	200
Investments at fair value	$ 189	$ 190
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 15,000	$ 15,000
Investments at cost	14,690	14,675
Investments at fair value	$ 14,690	$ 14,675
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 10,000	$ 10,000
Investments at cost	9,793	9,784
Investments at fair value	9,793	9,784
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	432	432
Investments at fair value	$ 368	$ 379
Number of Shares (in shares)	4,109	4,109
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,897	4,892
Investments at fair value	$ 4,897	$ 4,892
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,449	2,446
Investments at fair value	2,449	2,446
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	86	86
Investments at fair value	$ 1,299	$ 1,305
Number of Shares (in shares)	12,153	12,153
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.50%	11.50%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,764	4,757
Investments at fair value	$ 4,764	$ 4,757
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.50%	11.50%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,457	2,454
Investments at fair value	2,457	2,454
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	152	152
Investments at fair value	$ 138	$ 135
Number of Shares (in shares)	93,336	93,336
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.50%	11.50%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,457	2,454
Investments at fair value	$ 2,457	$ 2,454
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.25%	12%
Margin	2.75%	3.50%
Floor	9.25%	8.25%
Ceiling	0%	0%
ETP	4%	5.50%
Maturity Date	Mar. 01, 2029	Oct. 01, 2024
Principal Amount	$ 5,000	$ 3,750
Investments at cost	4,811	3,738
Investments at fair value	$ 4,811	$ 3,738
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	11.25%	12%
Margin	2.75%	3.50%
Floor	9.25%	8.25%
Ceiling	0%	0%
ETP	4%	5.50%
Maturity Date	Mar. 01, 2029	Oct. 01, 2024
Principal Amount	$ 5,000	$ 3,750
Investments at cost	4,932	3,738
Investments at fair value	4,932	3,738
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	139	69
Investments at fair value	$ 267	$ 229
Number of Shares (in shares)	219,866	145,483
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	11.25%	12%
Margin	2.75%	3.50%
Floor	9.25%	8.25%
Ceiling	0%	0%
ETP	4%	5.50%
Maturity Date	Mar. 01, 2029	Oct. 01, 2024
Principal Amount	$ 4,000	$ 1,875
Investments at cost	3,946	1,866
Investments at fair value	3,946	$ 1,866
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate		12%
Margin		3.50%
Floor		8.25%
Ceiling		0%
ETP		5.50%
Maturity Date		Oct. 01, 2024
Principal Amount		$ 1,875
Investments at cost		1,866
Investments at fair value		$ 1,866
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member]
Investments at cost	162
Investments at fair value	$ 182
Number of Shares (in shares)	4,635,992
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	8.75%	8.75%
Ceiling	0%	0%
ETP	6%	6%
Maturity Date	Aug. 01, 2026	Aug. 01, 2026
Principal Amount	$ 4,375	$ 4,583
Investments at cost	4,332	4,546
Investments at fair value	$ 4,332	$ 4,546
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	8.75%	8.75%
Ceiling	0%	0%
ETP	6%	6%
Maturity Date	Aug. 01, 2026	Aug. 01, 2026
Principal Amount	$ 2,188	$ 2,292
Investments at cost	2,166	2,273
Investments at fair value	2,166	2,273
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	0
Investments at fair value	$ 0
Number of Shares (in shares)	30,585
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost		149
Investments at fair value		$ 167
Number of Shares (in shares)		4,106,174
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.32%	13.32%
Margin	4.82%	4.82%
Floor	9.25%	9.25%
Ceiling	0%	0%
ETP	10.36%	10.36%
Maturity Date	Jul. 01, 2025	Jul. 01, 2025
Principal Amount	$ 3,911	$ 3,960
Investments at cost	3,864	3,923
Investments at fair value	$ 3,864	$ 3,923
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.32%	13.32%
Margin	4.82%	4.82%
Floor	9.25%	9.25%
Ceiling	0%	0%
ETP	10.36%	10.36%
Maturity Date	Jul. 01, 2025	Jul. 01, 2025
Principal Amount	$ 3,911	$ 3,960
Investments at cost	3,864	3,923
Investments at fair value	3,864	3,923
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	256	221
Investments at fair value	$ 247	$ 206
Number of Shares (in shares)	9,313,541	7,972,222
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.59%	13.59%
Margin	5.09%	5.09%
Floor	10%	10%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jan. 01, 2024	Jan. 01, 2024
Principal Amount	$ 391	$ 500
Investments at cost	391	500
Investments at fair value	$ 391	$ 500
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.59%	13.59%
Margin	5.09%	5.09%
Floor	10%	10%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Mar. 01, 2024	Jan. 01, 2024
Principal Amount	$ 533	$ 33
Investments at cost	533	33
Investments at fair value	533	33
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	174	174
Investments at fair value	$ 128	$ 124
Number of Shares (in shares)	3,341,376	3,341,376
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		13.59%
Margin		5.09%
Floor		10%
Ceiling		0%
ETP		5%
Maturity Date		Mar. 01, 2024
Principal Amount		$ 800
Investments at cost		794
Investments at fair value		794
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CVRx, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 76	76
Investments at fair value	$ 382	$ 980
Number of Shares (in shares)	47,410	47,410
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 124	$ 124
Investments at fair value	$ 50	$ 26
Number of Shares (in shares)	2,010,424	2,010,424
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 195	$ 194
Investments at fair value	$ 374	$ 368
Number of Shares (in shares)	809,931	809,931
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Meditrina, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 83	$ 83
Investments at fair value	$ 54	$ 93
Number of Shares (in shares)	233,993	233,993
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,691	3,689
Investments at fair value	$ 3,691	$ 3,689
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12.25%	12.25%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,691	3,689
Investments at fair value	3,691	3,689
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | MicroTransponder, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	47	47
Investments at fair value	$ 48	$ 47
Number of Shares (in shares)	103,172	103,172
Medical Device Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] | Common Stock [Member]
Investments at cost	$ 0	$ 0
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	660,537	660,537
Communications Sector [Member]
Investments at cost	$ 17,327	$ 19,192
Investments at fair value	$ 20,185	$ 22,188
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	9.25%	9.25%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 5,625	$ 6,250
Investments at cost	5,597	6,218
Investments at fair value	$ 5,597	$ 6,218
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	9.25%	9.25%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 5,625	$ 6,250
Investments at cost	5,597	6,218
Investments at fair value	5,597	6,218
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	46	47
Investments at fair value	$ 62	$ 61
Number of Shares (in shares)	1,991	1,991
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	9.25%	9.25%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 5,625	$ 6,250
Investments at cost	5,597	6,218
Investments at fair value	5,597	6,218
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Preferred Stock [Member]
Investments at cost	261	261
Investments at fair value	$ 306	$ 306
Number of Shares (in shares)	1,810	1,810
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Intelepeer Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 137	$ 138
Investments at fair value	$ 2,894	$ 3,036
Number of Shares (in shares)	2,936,535	2,936,535
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | PebblePost, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 92	$ 92
Investments at fair value	$ 132	$ 131
Number of Shares (in shares)	598,850	598,850
Software Sector [Member]
Investments at cost	$ 159,094	$ 164,133
Investments at fair value	$ 154,908	$ 160,749
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15%	15%
Margin	6.50%	6.50%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 6,701	$ 6,625
Investments at cost	6,607	6,519
Investments at fair value	$ 6,303	$ 6,176
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	15%	15%
Margin	6.50%	6.50%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 6,185	$ 6,116
Investments at cost	6,098	6,018
Investments at fair value	5,819	5,701
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	455	455
Investments at fair value	$ 56	$ 46
Number of Shares (in shares)	516,732	516,732
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	15%	15%
Margin	6.50%	6.50%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Aug. 01, 2026	Aug. 01, 2026
Principal Amount	$ 2,577	$ 2,548
Investments at cost	2,541	2,507
Investments at fair value	$ 2,425	$ 2,375
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 10,000	$ 10,000
Investments at cost	9,912	9,895
Investments at fair value	$ 9,540	$ 9,895
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 10,000	$ 10,000
Investments at cost	9,912	9,895
Investments at fair value	9,540	9,895
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	273	273
Investments at fair value	$ 11	$ 13
Number of Shares (in shares)	639,918	639,918
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,956	4,947
Investments at fair value	$ 4,770	$ 4,947
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,956	4,947
Investments at fair value	4,770	$ 4,947
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate		14.75%
Margin		6.25%
Floor		9.75%
Ceiling		0%
ETP		4.50%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 3,750
Investments at cost		3,728
Investments at fair value		$ 3,728
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Term Loan, Prime Index Two [Member]
Cash Rate		14.75%
Margin		6.25%
Floor		9.75%
Ceiling		0%
ETP		4.50%
Maturity Date		Jul. 01, 2027
Principal Amount		$ 3,750
Investments at cost		3,728
Investments at fair value		3,728
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	168	167
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	85,066	85,066
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 191	$ 192
Investments at fair value	$ 98	$ 99
Number of Shares (in shares)	652,250	652,250
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15%	15%
Margin	6.50%	6.50%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Mar. 01, 2026	Mar. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,977	4,971
Investments at fair value	$ 4,977	$ 4,971
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	15%	15%
Margin	6.50%	6.50%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Mar. 01, 2026	Mar. 01, 2026
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,489	2,486
Investments at fair value	2,489	2,486
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	34	32
Investments at fair value	$ 121	$ 120
Number of Shares (in shares)	101,308	101,308
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Medsphere Systems Corporation [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 60	$ 60
Investments at fair value	$ 134	$ 108
Number of Shares (in shares)	7,097,792	7,097,792
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 163	$ 163
Investments at fair value	$ 58	$ 50
Number of Shares (in shares)	150,353	150,353
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	14.25%	14.25%
Ceiling	0%	0%
ETP	5%	4%
Maturity Date	Nov. 01, 2026	Nov. 01, 2026
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,473	2,471
Investments at fair value	$ 2,473	$ 2,373
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	14.25%	14.25%
Ceiling	0%	0%
ETP	5%	4%
Maturity Date	Dec. 01, 2026	Dec. 01, 2026
Principal Amount	$ 1,250	$ 1,250
Investments at cost	1,239	1,237
Investments at fair value	1,239	1,188
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	43	43
Investments at fair value	$ 0	$ 1
Number of Shares (in shares)	85,543	85,543
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	14.25%	14.25%
Ceiling	0%	0%
ETP	5%	4%
Maturity Date	Apr. 01, 2027	Apr. 01, 2027
Principal Amount	$ 1,000	$ 1,000
Investments at cost	994	994
Investments at fair value	$ 994	$ 954
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,783	4,779
Investments at fair value	$ 4,783	$ 4,779
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,919	4,915
Investments at fair value	4,919	4,915
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	220	223
Investments at fair value	$ 253	$ 247
Number of Shares (in shares)	948,275	948,275
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,919	4,915
Investments at fair value	$ 4,919	$ 4,915
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,919	4,915
Investments at fair value	$ 4,919	$ 4,915
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.50%	13.50%
Margin	5%	5%
Floor	12%	12%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Mar. 01, 2027	Mar. 01, 2027
Principal Amount	$ 10,000	$ 10,000
Investments at cost	9,896	9,885
Investments at fair value	$ 9,896	$ 9,885
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.50%	13.50%
Margin	5%	5%
Floor	12%	12%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Mar. 01, 2027	Mar. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,947	4,942
Investments at fair value	4,947	4,942
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	116	115
Investments at fair value	$ 3	$ 2
Number of Shares (in shares)	84,037	84,037
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	13.50%	13.50%
Margin	5%	5%
Floor	12%	12%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date		Mar. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,947	4,942
Investments at fair value	$ 4,947	$ 4,942
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15.75%	15.75%
Margin	7.25%	7.25%
Floor	10.50%	10.50%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Aug. 01, 2025	Aug. 01, 2025
Principal Amount	$ 3,233	$ 3,667
Investments at cost	3,182	3,625
Investments at fair value	3,182	3,625
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	66	56
Investments at fair value	$ 83	$ 80
Number of Shares (in shares)	4,104	3,731
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Aug. 01, 2026	Aug. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,965	4,959
Investments at fair value	$ 4,965	$ 4,959
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Aug. 01, 2026	Aug. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,965	4,959
Investments at fair value	4,965	4,959
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	123	123
Investments at fair value	$ 85	$ 135
Number of Shares (in shares)	309,208	309,208
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate		14.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Aug. 01, 2026	Aug. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,965	4,959
Investments at fair value	$ 4,965	$ 4,959
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9.75%	9.75%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Aug. 01, 2026	Aug. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,965	4,959
Investments at fair value	4,965	4,959
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Preferred Stock [Member]
Investments at cost	2,800	2,800
Investments at fair value	$ 1,281	$ 1,281
Number of Shares (in shares)	280,000	280,000
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	12%	12%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,458	2,457
Investments at fair value	$ 2,458	$ 2,457
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	12%	12%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 3,500	$ 3,500
Investments at cost	3,490	3,489
Investments at fair value	3,490	3,489
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	64	64
Investments at fair value	$ 138	$ 135
Number of Shares (in shares)	682	682
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	12%	12%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,493	2,492
Investments at fair value	$ 2,493	$ 2,492
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12.75%	12.75%
Margin	4.25%	4.25%
Floor	12%	12%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Jun. 01, 2028	Jun. 01, 2028
Principal Amount	$ 1,500	$ 1,500
Investments at cost	1,496	1,495
Investments at fair value	1,496	1,495
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	18	18
Investments at fair value	$ 42	$ 42
Number of Shares (in shares)	71,305	71,305
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock [Member]
Investments at cost	$ 4	$ 4
Investments at fair value	$ 193	$ 193
Number of Shares (in shares)	66,127	66,127
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.50%	12.50%
Margin	4%	4%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,779	4,773
Investments at fair value	$ 4,779	$ 4,773
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12.50%	12.50%
Margin	4%	4%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,470	2,467
Investments at fair value	2,470	2,467
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Preferred Stock Warrants [Member]
Investments at cost	120	120
Investments at fair value	$ 211	$ 105
Number of Shares (in shares)	345,443	345,443
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	12.50%	12.50%
Margin	4%	4%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,470	2,467
Investments at fair value	$ 2,470	$ 2,467
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member]
Cash Rate	14%
Margin	5.50%
Floor	14%
Ceiling	0%
ETP	3%
Maturity Date	Apr. 01, 2029
Principal Amount	$ 2,500
Investments at cost	2,464
Investments at fair value	$ 2,464
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	14%	14%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,899	4,860
Investments at fair value	$ 4,899	$ 4,860
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	14%	14%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,467	2,466
Investments at fair value	2,467	2,466
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	98	98
Investments at fair value	$ 136	$ 174
Number of Shares (in shares)	161,215	161,215
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	14%	14%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,467	2,466
Investments at fair value	$ 2,467	$ 2,466
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	14%	14%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Oct. 01, 2028	Oct. 01, 2028
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,467	2,466
Investments at fair value	2,467	2,466
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | E La Carte, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	60	60
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	147,361	147,361
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Everstream Holdings, LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 70	$ 70
Investments at fair value	$ 63	$ 63
Number of Shares (in shares)	350,000	350,000
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Revinate Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 44	$ 44
Investments at fair value	$ 93	$ 91
Number of Shares (in shares)	682,034	682,034
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | SIGNiX, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 225	$ 225
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	186,235	186,235
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Topia Mobility, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 138	$ 138
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	3,049,607	3,049,607
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | xAd, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 177	$ 177
Investments at fair value	$ 8	$ 5
Number of Shares (in shares)	4,343,348	4,343,348
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15.75%	15.75%
Margin	7.25%	7.25%
Floor	10.50%	10.50%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 3,033	$ 3,383
Investments at cost	3,009	3,356
Investments at fair value	3,009	3,356
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	22	22
Investments at fair value	$ 28	$ 27
Number of Shares (in shares)	75,997	75,997
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	Aug. 01, 2025	Aug. 01, 2025
Principal Amount	$ 1,417	$ 1,667
Investments at cost	1,408	1,656
Investments at fair value	$ 1,408	$ 1,656
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.50%	5.50%
Maturity Date	Aug. 01, 2025	Aug. 01, 2025
Principal Amount	$ 1,417	$ 1,583
Investments at cost	1,408	1,573
Investments at fair value	1,408	1,573
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Preferred Stock Warrants [Member]
Investments at cost	30	29
Investments at fair value	$ 124	$ 122
Number of Shares (in shares)	46,745	46,745
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,729	3,608
Investments at fair value	$ 3,729	$ 3,608
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 1,250	$ 1,250
Investments at cost	1,243	1,242
Investments at fair value	1,243	1,242
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	95	94
Investments at fair value	$ 259	$ 250
Number of Shares (in shares)	37,282	37,282
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,729	3,726
Investments at fair value	$ 3,729	$ 3,726
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 1,250	$ 1,250
Investments at cost	1,243	1,242
Investments at fair value	$ 1,243	$ 1,242
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,729	3,726
Investments at fair value	$ 3,729	$ 3,726
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jul. 01, 2027	Jul. 01, 2027
Principal Amount	$ 1,250	$ 1,250
Investments at cost	1,243	1,242
Investments at fair value	$ 1,243	$ 1,242
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,716	3,712
Investments at fair value	$ 3,716	$ 3,712
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,716	3,712
Investments at fair value	$ 3,716	$ 3,712
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Nine [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,708	3,706
Investments at fair value	$ 3,708	$ 3,706
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Ten [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jul. 01, 2028	Jul. 01, 2028
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,709	3,707
Investments at fair value	$ 3,709	$ 3,707
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eleven [Member]
Cash Rate	11.25%	11.25%
Margin	6%	6%
Floor	9.50%	9.50%
Ceiling	11.25%	11.25%
ETP	3%	3%
Maturity Date	Jul. 01, 2028	Jul. 01, 2028
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,709	3,707
Investments at fair value	3,709	3,707
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	93	93
Investments at fair value	$ 3	$ 0
Number of Shares (in shares)	20,000	20,000
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Aterian, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 195	$ 195
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	6,140	76,923
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Caastle, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 68	$ 65
Investments at fair value	$ 2,167	$ 1,055
Number of Shares (in shares)	268,591	268,591
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | CZV, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	$ 81	$ 81
Investments at fair value	$ 73	$ 71
Number of Shares (in shares)	65,569	65,569
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	13.50%	13.50%
Margin	5%	5%
Floor	5%	5%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Mar. 01, 2027	Mar. 01, 2027
Principal Amount	$ 2,000	$ 2,000
Investments at cost	1,505	1,421
Investments at fair value	$ 1,505	$ 1,421
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	13.50%	13.50%
Margin	5%	5%
Floor	5%	5%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Mar. 01, 2027	Mar. 01, 2027
Principal Amount	$ 3,000	$ 3,000
Investments at cost	2,258	2,131
Investments at fair value	2,258	2,131
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	2,947	2,947
Investments at fair value	$ 2,260	$ 2,259
Number of Shares (in shares)	1,312,500	1,312,500
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	10.50%	10.50%
Ceiling	0%	0%
ETP	7.78%	7.78%
Maturity Date	Feb. 01, 2028	Feb. 01, 2028
Principal Amount	$ 2,813	$ 2,813
Investments at cost	2,813	2,813
Investments at fair value	$ 2,813	$ 2,813
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	10.50%	10.50%
Ceiling	0%	0%
ETP	7.78%	7.78%
Maturity Date	Feb. 01, 2028	Feb. 01, 2028
Principal Amount	$ 2,813	$ 2,813
Investments at cost	2,813	2,813
Investments at fair value	$ 2,813	$ 2,813
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Oct. 01, 2025	Oct. 01, 2025
Principal Amount	$ 3,000	$ 3,667
Investments at cost	2,986	3,647
Investments at fair value	$ 2,986	$ 3,647
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Oct. 01, 2025	Oct. 01, 2025
Principal Amount	$ 1,500	$ 1,833
Investments at cost	1,493	1,824
Investments at fair value	1,493	1,824
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Preferred Stock Warrants [Member]
Investments at cost	29	29
Investments at fair value	$ 58	$ 56
Number of Shares (in shares)	250	250
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Getaround, Inc [Member] | Common Stock [Member]
Investments at cost	$ 253	$ 253
Investments at fair value	$ 27	$ 20
Number of Shares (in shares)	87,082	87,082
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 5,744	$ 5,752
Investments at cost	5,744	5,752
Investments at fair value	$ 5,014	$ 5,018
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 2,298	$ 2,301
Investments at cost	2,298	2,301
Investments at fair value	2,006	2,007
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	188	188
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	12,618	12,618
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 9	$ 9
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	1,224,752	1,224,752
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 2,872	$ 2,876
Investments at cost	2,872	2,876
Investments at fair value	2,507	2,509
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock [Member]
Investments at cost	89	89
Investments at fair value	$ 0	$ 89
Number of Shares (in shares)	2,688,971	2,688,971
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 3,446	$ 3,451
Investments at cost	3,446	3,451
Investments at fair value	$ 3,009	$ 3,011
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 2,872	$ 2,876
Investments at cost	2,872	2,876
Investments at fair value	$ 2,507	$ 2,510
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 2,872	$ 2,876
Investments at cost	2,872	2,876
Investments at fair value	$ 2,507	$ 2,510
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 5,744	$ 5,752
Investments at cost	5,744	5,752
Investments at fair value	$ 5,014	$ 5,018
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate	14.25%	14.25%
Margin	5.75%	5.75%
Floor	9%	9%
Ceiling	0%	0%
ETP	5.25%	5.25%
Maturity Date	Oct. 31, 2023	Oct. 31, 2023
Principal Amount	$ 2,872	$ 2,876
Investments at cost	2,872	2,876
Investments at fair value	2,507	2,510
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | SnagAJob.com, Inc [Member] | Common Stock [Member]
Investments at cost	10	9
Investments at fair value	$ 80	$ 83
Number of Shares (in shares)	82,974	82,974
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Lyrical Foods, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	9%	9%
Ceiling	0%	0%
ETP	1%	1%
Maturity Date	Sep. 01, 2027	Sep. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,590	2,591
Investments at fair value	$ 2,435	$ 2,429
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.75%	14.75%
Margin	6.25%	6.25%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,424	2,416
Investments at fair value	$ 2,424	$ 2,416
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.75%	14.75%
Margin	6.25%	6.25%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Jul. 01, 2028	Jul. 01, 2028
Principal Amount	$ 1,875	$ 1,875
Investments at cost	1,791	1,787
Investments at fair value	1,791	1,787
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	179	182
Investments at fair value	$ 145	$ 145
Number of Shares (in shares)	11,550	11,550
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 57	$ 57
Investments at fair value	$ 593	$ 591
Number of Shares (in shares)	553,778	553,778
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Quip NYC Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 325	$ 325
Investments at fair value	$ 232	$ 533
Number of Shares (in shares)	6,191	6,191
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	16.25%	16.25%
Margin	7.75%	7.75%
Floor	11%	11%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	May 01, 2027	May 01, 2027
Principal Amount	$ 1,254	$ 1,204
Investments at cost	1,086	1,086
Investments at fair value	$ 570	$ 872
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	16.25%	16.25%
Margin	7.75%	7.75%
Floor	11%	11%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	May 01, 2027	May 01, 2027
Principal Amount	$ 627	$ 602
Investments at cost	543	543
Investments at fair value	285	436
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	32	32
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	171,081	171,081
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	16.25%	16.25%
Margin	7.75%	7.75%
Floor	11%	11%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	May 01, 2027	May 01, 2027
Principal Amount	$ 627	$ 602
Investments at cost	543	543
Investments at fair value	285	436
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Updater, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	34	34
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	114,659	114,659
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member]
Investments at cost	$ 5,505	$ 5,335
Investments at fair value	$ 5,143	$ 4,969
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12%	12%
Ceiling	0%	0%
ETP	2.78%	1.85%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 3,658	$ 3,547
Investments at cost	3,698	3,585
Investments at fair value	$ 3,455	$ 3,339
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12.25%	12.25%
Margin	3.75%	3.75%
Floor	12%	12%
Ceiling	0%	0%
ETP	2.78%	1.85%
Maturity Date	Aug. 01, 2029	Aug. 01, 2029
Principal Amount	$ 1,829	$ 1,773
Investments at cost	1,807	1,750
Investments at fair value	1,688	1,630
Other Sustainability Sector [Member]
Investments at cost	100,854	98,906
Investments at fair value	71,060	80,370
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	1,001	999
Investments at fair value	$ 559	$ 542
Number of Shares (in shares)
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	4.33%	4.33%
Maturity Date	Dec. 01, 2026	Dec. 01, 2026
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,695	3,685
Investments at fair value	$ 3,695	$ 3,685
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	4.33%	4.33%
Maturity Date	Dec. 01, 2026	Dec. 01, 2026
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,695	3,685
Investments at fair value	3,695	3,685
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	81	81
Investments at fair value	$ 74	$ 72
Number of Shares (in shares)	400,000	400,000
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | LiquiGlide, Inc [Member] | Common Stock Warrants [Member]
Investments at cost		$ 39
Investments at fair value		$ 50
Number of Shares (in shares)		61,359
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | LiquiGlide, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 39
Investments at fair value	$ 51
Number of Shares (in shares)	61,359
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 8,759	$ 8,425
Investments at cost	8,431	8,353
Investments at fair value	$ 2,477	$ 4,549
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 8,759	$ 8,425
Investments at cost	8,229	8,229
Investments at fair value	2,418	4,481
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	490	490
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	215,171	215,171
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 8,759	$ 8,425
Investments at cost	8,229	8,229
Investments at fair value	$ 2,418	$ 4,481
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 5,840	$ 5,617
Investments at cost	5,480	5,480
Investments at fair value	$ 1,610	$ 2,984
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 5,840	$ 5,617
Investments at cost	5,480	5,480
Investments at fair value	$ 1,610	$ 2,984
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 764	$ 735
Investments at cost	726	726
Investments at fair value	$ 213	$ 395
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 609	$ 586
Investments at cost	578	578
Investments at fair value	$ 170	$ 315
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eight [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 304	$ 292
Investments at cost	288	288
Investments at fair value	$ 85	$ 157
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Nine [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 301	$ 290
Investments at cost	286	286
Investments at fair value	$ 84	$ 156
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Ten [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 181	$ 174
Investments at cost	172	172
Investments at fair value	$ 50	$ 93
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eleven [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 833	$ 802
Investments at cost	791	791
Investments at fair value	$ 232	$ 431
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Fixed Index One [Member]
Cash Rate	15.50%
Margin	0%
Floor	0%
Ceiling	0%
ETP	0%
Maturity Date	Apr. 30, 2024
Principal Amount	$ 418
Investments at cost	397
Investments at fair value	$ 117
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Fixed Index Two [Member]
Cash Rate	15.50%
Margin	0%
Floor	0%
Ceiling	0%
ETP	0%
Maturity Date	Apr. 30, 2024
Principal Amount	$ 552
Investments at cost	502
Investments at fair value	$ 147
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Fixed Index Three [Member]
Cash Rate	15.50%
Margin	0%
Floor	0%
Ceiling	0%
ETP	0%
Maturity Date	Apr. 30, 2024
Principal Amount	$ 411
Investments at cost	405
Investments at fair value	$ 119
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Twelve [Member]
Cash Rate	15.50%	15.50%
Margin	7%	7%
Floor	10.25%	10.25%
Ceiling	0%	0%
ETP	0%	0%
Maturity Date	Mar. 31, 2024	Mar. 31, 2024
Principal Amount	$ 1,134	$ 1,091
Investments at cost	1,083	1,083
Investments at fair value	$ 318	$ 590
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Fixed Index Four [Member]
Cash Rate	15.50%
Margin	0%
Floor	0%
Ceiling	0%
ETP	0%
Maturity Date	Apr. 30, 2024
Principal Amount	$ 487
Investments at cost	486
Investments at fair value	$ 143
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	2.75%	2.75%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,967	4,959
Investments at fair value	$ 4,967	$ 4,959
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	2.75%	2.75%
Maturity Date	Apr. 01, 2026	Apr. 01, 2026
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,483	2,479
Investments at fair value	2,483	2,479
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	216	214
Investments at fair value	$ 350	$ 340
Number of Shares (in shares)	681	681
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	2.75%	2.75%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,964	4,956
Investments at fair value	$ 4,964	$ 4,956
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	2.75%	2.75%
Maturity Date	May 01, 2026	May 01, 2026
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,482	2,478
Investments at fair value	$ 2,482	$ 2,478
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	2.75%	2.75%
Maturity Date	Dec. 01, 2026	Dec. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,942	4,934
Investments at fair value	$ 4,942	$ 4,934
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	2.75%	2.75%
Maturity Date	Dec. 01, 2026	Dec. 01, 2026
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,471	2,467
Investments at fair value	$ 2,471	$ 2,467
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,697	3,694
Investments at fair value	$ 3,697	$ 3,694
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,697	3,694
Investments at fair value	3,697	3,694
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	175	175
Investments at fair value	$ 84	$ 80
Number of Shares (in shares)	46,311	46,311
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 7,500	$ 7,500
Investments at cost	7,386	7,379
Investments at fair value	$ 7,386	$ 7,379
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,693	3,690
Investments at fair value	$ 3,693	$ 3,690
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	15.25%	15.25%
Margin	6.75%	6.75%
Floor	10%	10%
Ceiling	0%	0%
ETP	2.50%	2.50%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 3,750	$ 3,750
Investments at cost	3,693	3,690
Investments at fair value	$ 3,693	$ 3,690
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Six [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	10%	10%
Ceiling	0%	0%
ETP	2%	2%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 4,500	$ 4,500
Investments at cost	4,448	4,446
Investments at fair value	$ 4,448	$ 4,446
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Seven [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	10%	10%
Ceiling	0%	0%
ETP	2%	2%
Maturity Date	Jan. 01, 2029	Jan. 01, 2029
Principal Amount	$ 2,000	$ 2,000
Investments at cost	1,977	1,976
Investments at fair value	1,977	1,976
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Common Stock [Member]
Investments at cost	111	111
Investments at fair value	$ 8	$ 13
Number of Shares (in shares)	5,205	5,205
Diagnostics Sector [Member]
Investments at cost	$ 19,759	$ 19,735
Investments at fair value	$ 19,729	$ 19,701
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	9.25%	9.25%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,487	2,484
Investments at fair value	$ 2,487	$ 2,484
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	9.25%	9.25%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 2,500	$ 2,500
Investments at cost	2,487	2,484
Investments at fair value	2,487	2,484
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	47	46
Investments at fair value	$ 12	$ 12
Number of Shares (in shares)	171,370	171,370
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	14.50%	14.50%
Margin	6%	6%
Floor	9.25%	9.25%
Ceiling	0%	0%
ETP	3.50%	3.50%
Maturity Date	Jun. 01, 2026	Jun. 01, 2026
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,973	4,968
Investments at fair value	$ 4,973	$ 4,968
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.75%	11.75%
Margin	3.25%	3.25%
Floor	11.50%	11.50%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,639	4,633
Investments at fair value	$ 4,639	$ 4,633
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	11.75%	11.75%
Margin	3.25%	3.25%
Floor	11.50%	11.50%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jan. 01, 2028	Jan. 01, 2028
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,890	4,884
Investments at fair value	4,890	4,884
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Common Stock Warrants [Member]
Investments at cost	70	70
Investments at fair value	$ 70	$ 70
Number of Shares (in shares)	32,244	32,244
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 166	$ 166
Investments at fair value	$ 171	$ 166
Number of Shares (in shares)	184,253	184,253
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	$ 264,468	$ 275,026
Investments at fair value	257,817	269,790
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	9,741	9,733
Investments at fair value	15,275	14,506
Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member]
Investments at cost	4,060	3,311
Investments at fair value	2,656	3,024
Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Common Stock [Member]
Investments at cost	2,060	2,061
Investments at fair value	$ 659	$ 2,165
Number of Shares (in shares)	2,278,272	2,278,272
Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Preferred Stock [Member]
Investments at cost	$ 2,000	$ 1,250
Investments at fair value	$ 1,997	$ 859
Number of Shares (in shares)	4,458,452	3,124,448
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	$ 256,228	$ 249,642
Investments at fair value	254,853	244,815
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Other Investments [Member]
Investments at cost	8,381	1,200
Investments at fair value	3,347	200
Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member]
Investments at cost	23,564	23,551
Investments at fair value		1,000
Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member]
Investments at cost	5,000	5,000
Investments at fair value	$ 0	$ 132
Number of Shares (in shares)
Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member]
Investments at cost	$ 5,463	$ 5,782
Investments at fair value	5,845	6,230
Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Other Investments [Member]
Investments at cost	5,463	5,782
Investments at fair value	5,845	6,230
Other Healthcare Sector [Member]
Investments at cost	102	102
Investments at fair value	949	1,366
Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kate Farms, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	102	102
Investments at fair value	$ 949	$ 1,366
Number of Shares (in shares)	82,965	82,965
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	$ 69,882	$ 69,770
Investments at fair value	69,882	69,770
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	967	966
Investments at fair value	1,492	1,871
Data Storage Sector [Member]
Investments at cost	416	417
Investments at fair value	426	418
Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | CPG Beyond, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	241	242
Investments at fair value	$ 298	$ 294
Number of Shares (in shares)	500,000	500,000
Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Silk, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 175	$ 175
Investments at fair value	$ 128	$ 124
Number of Shares (in shares)	394,110	394,110
Internet and Media Sector [Member]
Investments at cost	$ 328	$ 329
Investments at fair value	1,592	1,582
Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Global Worldwide LLC [Member] | Preferred Stock Warrants [Member]
Investments at cost	74	75
Investments at fair value	$ 63	$ 63
Number of Shares (in shares)	245,810	245,810
Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Rocket Lawyer Incorporated [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 92	$ 92
Investments at fair value	$ 323	$ 318
Number of Shares (in shares)	261,721	261,721
Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Skillshare, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	$ 162	$ 162
Investments at fair value	$ 1,206	$ 1,201
Number of Shares (in shares)	139,074	139,074
Networking Sector [Member]
Investments at cost	$ 3,231	$ 5,451
Investments at fair value	$ 3,091	$ 5,297
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14.75%	14.75%
Margin	6.25%	6.25%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Sep. 01, 2024	Sep. 01, 2024
Principal Amount	$ 833	$ 1,500
Investments at cost	822	1,481
Investments at fair value	$ 822	$ 1,481
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14.75%	14.75%
Margin	6.25%	6.25%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Sep. 01, 2024	Sep. 01, 2024
Principal Amount	$ 833	$ 1,500
Investments at cost	822	1,481
Investments at fair value	822	1,481
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	364	364
Investments at fair value	$ 224	$ 210
Number of Shares (in shares)	344,102	344,102
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	14.75%	14.75%
Margin	6.25%	6.25%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Sep. 01, 2024	Sep. 01, 2024
Principal Amount	$ 417	$ 750
Investments at cost	410	740
Investments at fair value	$ 410	$ 740
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	14.75%	14.75%
Margin	6.25%	6.25%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Sep. 01, 2024	Sep. 01, 2024
Principal Amount	$ 417	$ 667
Investments at cost	410	656
Investments at fair value	$ 410	$ 656
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Five [Member]
Cash Rate	14.75%	14.75%
Margin	6.25%	6.25%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Sep. 01, 2024	Sep. 01, 2024
Principal Amount	$ 417	$ 750
Investments at cost	403	729
Investments at fair value	403	729
Power Management Sector [Member]
Investments at cost	1,585	1,585
Investments at fair value	2,700	2,700
Power Management Sector [Member] | Investment, Unaffiliated Issuer [Member] | Halio, Inc [Member] | Common Stock Warrants [Member]
Investments at cost	1,585	1,585
Investments at fair value	$ 2,700	$ 2,700
Number of Shares (in shares)	38,241,466	38,241,466
Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	$ 4,802	$ 4,702
Investments at fair value	6,602	7,675
Semiconductor Sector [Member]
Investments at cost	45	45
Investments at fair value	0	0
Semiconductor Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalanche Technology, Inc [Member] | Preferred Stock Warrants [Member]
Investments at cost	45	45
Investments at fair value	$ 0	$ 0
Number of Shares (in shares)	5,938	5,938
Software, Healthcare Information and Service [Member]
Investments at cost	$ 50,988	$ 50,899
Investments at fair value	$ 50,696	$ 50,574
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 7,000	$ 7,000
Investments at cost	6,727	6,684
Investments at fair value	$ 6,727	$ 6,684
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 3,500	$ 3,500
Investments at cost	3,466	3,463
Investments at fair value	$ 3,466	$ 3,463
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Aug. 01, 2027	Aug. 01, 2027
Principal Amount	$ 3,500	$ 3,500
Investments at cost	3,466	3,463
Investments at fair value	$ 3,466	$ 3,463
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	14%	14%
Margin	5.50%	5.50%
Floor	9.50%	9.50%
Ceiling	0%	0%
ETP	3%	3%
Maturity Date	Apr. 01, 2028	Apr. 01, 2028
Principal Amount	$ 2,750	$ 2,750
Investments at cost	2,713	2,710
Investments at fair value	$ 2,713	$ 2,710
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Oct. 01, 2027	Oct. 01, 2027
Principal Amount	$ 10,000	$ 10,000
Investments at cost	9,666	9,656
Investments at fair value	$ 9,666	$ 9,656
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Oct. 01, 2027	Oct. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,930	4,925
Investments at fair value	$ 4,930	$ 4,925
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Three [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Oct. 01, 2027	Oct. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,930	4,925
Investments at fair value	$ 4,930	$ 4,925
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, Four [Member]
Cash Rate	12%	12%
Margin	3.50%	3.50%
Floor	11.75%	11.75%
Ceiling	0%	0%
ETP	4%	4%
Maturity Date	Oct. 01, 2027	Oct. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,930	4,925
Investments at fair value	$ 4,930	$ 4,925
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, One [Member]
Cash Rate	11.75%	11.75%
Margin	3.25%	3.25%
Floor	11%	11%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,654	4,648
Investments at fair value	$ 4,654	$ 4,648
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index Two [Member]
Cash Rate	11.75%	11.75%
Margin	3.25%	3.25%
Floor	11%	11%
Ceiling	0%	0%
ETP	5%	5%
Maturity Date	Jun. 01, 2027	Jun. 01, 2027
Principal Amount	$ 5,000	$ 5,000
Investments at cost	4,924	4,918
Investments at fair value	4,924	4,918
Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	99,853	97,907
Investments at fair value	$ 70,501	$ 79,828

Consolidated Schedule of Inve_5

Consolidated Schedule of Investments (Unaudited) - Investments (Details) (Parentheticals)	Mar. 31, 2024	Dec. 31, 2023
NAV %	214.10%	218.90%
Investment, Affiliated Issuer, Controlled [Member]
NAV %	4.10%	4.40%
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Debt Securities [Member]
NAV %	1.50%	1.60%
Investment, Affiliated Issuer, Controlled [Member] | Life Science [Member] | Other Investments [Member]
NAV %	1.80%	1.90%
Investment, Affiliated Issuer, Controlled [Member] | Technology Sector [Member] | Equity Securities [Member]
NAV %	0.80%	0.90%
Investment, Affiliated Issuer, Noncontrolled [Member]
NAV %		0.30%
Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member]
NAV %	3.80%
Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member] | Debt Securities [Member]
NAV %	3.80%	0.30%
Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member] | Equity Securities [Member]
NAV %	0%	0%
Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member] | Warrant [Member]
NAV %	0%	0%
Investment, Unaffiliated Issuer [Member]
NAV %	206.20%	214.20%
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
NAV %	196.60%	205%
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member]
NAV %	1.40%	1.50%
Investment, Unaffiliated Issuer [Member] | Warrant [Member]
NAV %	7.20%	7.60%
Investment, Unaffiliated Issuer [Member] | Life Science [Member] | Debt Securities [Member]
NAV %		75.60%
Investment, Unaffiliated Issuer [Member] | Life Science [Member] | Other Investments [Member]
NAV %	1%	0.10%
Investment, Unaffiliated Issuer [Member] | Life Science [Member] | Debt Investments [Member]
NAV %	76.80%
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Debt Securities [Member]
NAV %	77.60%	83.30%
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Warrant [Member]
NAV %	4.60%	4.50%
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Debt Securities [Member]
NAV %	21%	21.50%
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Warrant [Member]
NAV %	0.40%	0.60%
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Warrant [Member]
NAV %	2%	2.30%
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Debt Securities [Member]
NAV %	21.20%	24.60%
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Warrant [Member]
NAV %	0.20%	0.20%

Note 1 - Organization (Details

Note 1 - Organization (Details Textual) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023	Aug. 13, 2019
Debt Instrument, Face Amount	$ 615	$ 615
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Co-lender [Member]
Subsidiary, Ownership Percentage, Noncontrolling Owner	30%
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Co-lender [Member]
Investment Owned, Net Assets, Percentage		30%
Horizon Technology Finance Corporation [Member] | Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investment Owned, Net Assets, Percentage	70%	70%
Asset-backed Notes 2019 [Member]
Debt Instrument, Face Amount			$ 160
Asset-backed Notes 2019 [Member] | Affiliated Entity [Member]
Debt Instrument, Face Amount			$ 100

Note 2 - Basis of Presentatio_2

Note 2 - Basis of Presentation and Significant Accounting Policies (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		35 Months Ended
	Apr. 30, 2024	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Apr. 26, 2024	Dec. 31, 2023	Sep. 22, 2023	Aug. 02, 2021
Investments, Nonaccrual, Interest Income		$ 0	$ 0
Investment, Income Attributable to Non-cash Paid-in-Kind Interest, Percent		5.30%	4.30%
Interest Income, Operating, Paid in Kind		$ 1,382	$ 1,204
Investment, Nonaccrual, Income Not Received in Cash, Percent		6.80%	6.30%
Debt Issuance Costs, Net		$ 5,400		$ 5,400		$ 5,800
Accumulated Amortization, Debt Issuance Costs		5,600		$ 5,600		5,200
Amortization of Debt Issuance Costs		$ 393	$ 478
Federal Excise Tax, Percent		4%		4%
Excise and Sales Taxes		$ 400	200
Unrecognized Tax Benefits, Ending Balance		$ 0		$ 0		0
Open Tax Year		2024 2023 2022 2021
Proceeds from Issuance of Common Stock		$ 11,972	$ 7,174
Stock Repurchased During Period, Shares (in shares)		0	0	167,465
Stock Repurchased During Period, Per Share (in dollars per share)				$ 11.22
Stock Repurchased During Period, Value				$ 1,900
Subsequent Event [Member]
Share Repurchase Program, Authorized, Amount					$ 5,000
The 2021 Equity Distribution Agreement [Member]
Equity Sales Agreement, Maximum Value								$ 100,000
Equity Sales Agreement, Remaining Amount Available for Issuance							$ 0
Stock Issued During Period, Shares, New Issues (in shares)			605,848
Proceeds from Issuance of Common Stock			$ 7,200
Payments of Stock Issuance Costs			200
The 2023 Equity Distribution Agreement [Member]
Equity Sales Agreement, Maximum Value							$ 150,000
Equity Sales Agreement, Remaining Amount Available for Issuance		$ 134,500		134,500
Stock Issued During Period, Shares, New Issues (in shares)		1,053,796
Proceeds from Issuance of Common Stock		$ 12,000
Payments of Stock Issuance Costs		300
The 2023 Equity Distribution Agreement [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues (in shares)	526,581
Proceeds from Issuance of Common Stock	$ 5,800
Payments of Stock Issuance Costs	$ 100
Four Investments [Member]
Investments, Cost, Nonaccrual Status		96,000		96,000		72,500
Investments, Fair Value, Nonaccrual Status		51,000		$ 51,000		$ 27,600
One Investment [Member]
Interest Income, Operating, Paid in Kind		$ 1,000
Two Investments [Member]
Interest Income, Operating, Paid in Kind			$ 1,100

Note 3 - Related Party Transa_2

Note 3 - Related Party Transactions (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Management Fee Payable	$ 1,058		$ 1,052
Management Fee Expense	3,162	$ 3,201
Incentive Fee Payable	295		0
Administrative Fees Expense	$ 433	440
Investment Management Agreement [Member]
Base Management Fee, Annual, Percent	2%
Base Management Fee, Annual, Percent, Gross Assets Exceeding $250 Million	1.60%
Management Fee Payable	$ 1,100		1,100
Incentive Fee to Pre-incentive Net Investment Income	20%
Pre-Incentive Fee Net Investment Income, Hurdle Rate	1.75%
Pre-Incentive Fee Net Investment Income, Hurdle Rate, Annualized	7%
Pre-Incentive Fee Net Investment Income, Catch-up, Percent	100%
Pre-Incentive Fee Net Investment Income, Maximum Rate to Trigger Catch-up	2.1875%
Pre-Incentive Fee Net Investment Income, Maximum Rate to Trigger Catch-up, Annualized	8.75%
Incentive Fee Expense	$ 300	3,000
Incentive Fee Cap and Deferral Mechanism Reduction to Expense	2,300	200
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	13,100
Incentive Fee Payable	300		$ 0
Investment Management Agreement [Member] | December 31, 2025 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	1,000
Investment Management Agreement [Member] | March 31, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	200
Investment Management Agreement [Member] | June 30, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	3,100
Investment Management Agreement [Member] | September 30, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	3,500
Investment Management Agreement [Member] | December 31, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	3,000
Investment Management Agreement [Member] | March 31, 2027 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	2,300
Administration Agreement [Member]
Administrative Fees Expense	400	400
Administrative Fees Payable	$ 400	$ 400

Note 4 - Investments - Investme

Note 4 - Investments - Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Investments at cost	$ 765,173	$ 759,182
Investments at fair value	711,116	709,085
Biotechnology Sector [Member]
Investments at cost	142,108	145,544
Investments at fair value	124,741	117,781
Medical Device Sector [Member]
Investments at cost	164,060	147,064
Investments at fair value	161,155	145,019
Communications Sector [Member]
Investments at cost	17,327	19,192
Investments at fair value	20,185	22,188
Consumer-related Sector [Member]
Investments at cost	105,165	105,669
Investments at fair value	99,876	101,327
Data Storage Sector [Member]
Investments at cost	416	417
Investments at fair value	426	418
Internet and Media Sector [Member]
Investments at cost	328	329
Investments at fair value	1,592	1,582
Networking Sector [Member]
Investments at cost	3,231	5,451
Investments at fair value	3,091	5,297
Power Management Sector [Member]
Investments at cost	1,585	1,585
Investments at fair value	2,700	2,700
Semiconductor Sector [Member]
Investments at cost	45	45
Investments at fair value	0	0
Software Sector [Member]
Investments at cost	159,094	164,133
Investments at fair value	154,908	160,749
Energy Efficiency [Member]
Investments at cost	111	111
Investments at fair value	8	13
Other Sustainability Sector [Member]
Investments at cost	100,854	98,906
Investments at fair value	71,060	80,370
Diagnostics Sector [Member]
Investments at cost	19,759	19,735
Investments at fair value	19,729	19,701
Other Healthcare Sector [Member]
Investments at cost	102	102
Investments at fair value	949	1,366
Software, Healthcare Information and Service [Member]
Investments at cost	50,988	50,899
Investments at fair value	50,696	50,574
Debt [Member]
Investments at cost	719,500	721,231
Investments at fair value	670,773	670,172
Warrant [Member]
Investments at cost	16,636	16,526
Investments at fair value	23,928	24,594
Other Debt Obligations [Member]
Investments at cost	13,844	6,982
Investments at fair value	9,192	6,430
Equity Securities [Member]
Investments at cost	15,193	14,443
Investments at fair value	$ 7,223	$ 7,889

Note 5 - Transactions With Af_3

Note 5 - Transactions With Affiliated Companies (Details Textual) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Investment, Affiliated Issuer, Controlled [Member]
Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)	$ 0

Note 5 - Transactions With Af_4

Note 5 - Transactions With Affiliated Companies - Investments in Controlled Affiliated Companies (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Investments, fair value	$ 709,085
Net unrealized appreciation (depreciation) on investments	(3,960)	$ (7,537)
Net realized gain (loss) on investments	8	(168)
Investments, fair value	711,116
Interest Income, Operating, Paid in Kind	1,382	1,204
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments, fair value	1,132	0
Purchases	15	0
Reductions	0	0
Transfers in/(out) at fair value	0	0
Discount accretion	0	0
Net unrealized appreciation (depreciation) on investments	11,433	846
Net realized gain (loss) on investments	(3)	0
Investments, fair value	12,577	846
Interest income	0	0
Reductions	0	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member]
Investments, fair value	0
Purchases	3
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	0
Net realized gain (loss) on investments	(3)
Investments, fair value	0
Interest income	0
Reductions	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member]
Investments, fair value		0
Purchases		0
Reductions		0
Transfers in/(out) at fair value		0
Discount accretion		0
Net unrealized appreciation (depreciation) on investments		846
Net realized gain (loss) on investments		0
Investments, fair value		846
Interest income		0
Reductions		0
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment One [Member]
Investments, fair value	222
Purchases	0
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	2,568
Net realized gain (loss) on investments	0
Investments, fair value	2,790
Interest income	0
Reductions	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Two [Member]
Investments, fair value	336
Purchases	12
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	3,859
Net realized gain (loss) on investments	0
Investments, fair value	4,207
Interest income	0
Reductions	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Three [Member]
Investments, fair value	133
Purchases	0
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	1,541
Net realized gain (loss) on investments	0
Investments, fair value	1,674
Interest income	0
Reductions	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Four [Member]
Investments, fair value	133
Purchases	0
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	1,541
Net realized gain (loss) on investments	0
Investments, fair value	1,674
Interest income	0
Reductions	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Five [Member]
Investments, fair value	88
Purchases	0
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	1,028
Net realized gain (loss) on investments	0
Investments, fair value	1,116
Interest income	0
Reductions	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Six [Member]
Investments, fair value	88
Purchases	0
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	1,028
Net realized gain (loss) on investments	0
Investments, fair value	1,116
Interest income	0
Reductions	0
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Seven [Member]
Investments, fair value	132
Purchases	0
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	(132)
Net realized gain (loss) on investments	0
Investments, fair value	0
Interest income	0
Reductions	0
Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	14,223
Purchases	977
Reductions	547
Transfers in/(out) at fair value	0
Discount accretion	4
Net unrealized appreciation (depreciation) on investments	(1,179)	0
Net realized gain (loss) on investments	0
Investments, fair value	13,644
Interest income	11	0
Reductions	(547)
Interest Income, Operating, Paid in Kind	166	$ 0
Investment, Affiliated Issuer, Controlled [Member] | Investment [Member]
Interest income	177
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment One [Member]
Investments, fair value	3,339
Purchases	0
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	2
Net unrealized appreciation (depreciation) on investments	3
Net realized gain (loss) on investments	0
Investments, fair value	3,455
Interest income	116
Reductions	0
Interest Income, Operating, Paid in Kind	111
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Two [Member]
Investments, fair value	1,630
Purchases	0
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	2
Net unrealized appreciation (depreciation) on investments	1
Net realized gain (loss) on investments	0
Investments, fair value	1,688
Interest income	61
Reductions	0
Interest Income, Operating, Paid in Kind	55
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Three [Member]
Investments, fair value	3,024
Purchases	750
Reductions	0
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	(1,118)
Net realized gain (loss) on investments	0
Investments, fair value	2,656
Interest income	0
Reductions	0
Interest Income, Operating, Paid in Kind	0
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investments, fair value	6,230
Purchases	227
Reductions	547
Transfers in/(out) at fair value	0
Discount accretion	0
Net unrealized appreciation (depreciation) on investments	(65)
Net realized gain (loss) on investments	0
Investments, fair value	5,845
Interest income	0
Reductions	(547)
Interest Income, Operating, Paid in Kind	$ 0

Note 6 - Fair Value (Details Te

Note 6 - Fair Value (Details Textual) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares	Mar. 31, 2023 USD ($)	Jun. 30, 2022
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3	$ 0
Unrealized Gain (Loss) on Investments	(3,960)	$ (7,537)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		0
Fair Value, Inputs, Level 1 [Member] | Warrants and Equity Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Fair Value, Inputs, Level 3 [Member] | Debt Securities [Member]
Unrealized Gain (Loss) on Investments	(1,800)	(4,600)
Fair Value, Inputs, Level 3 [Member] | Equity Securities [Member]
Unrealized Gain (Loss) on Investments	$ (1,200)	(200)
Fair Value, Inputs, Level 3 [Member] | Warrant [Member]
Unrealized Gain (Loss) on Investments		$ (1,400)
The 2026 Notes [Member]
Debt Instrument, Share Price (in dollars per share) | $ / shares	$ 23.75
The 2026 Notes [Member] | Fair Value, Inputs, Level 1 [Member]
Debt Instrument, Fair Value Disclosure	$ 54,600
The 2027 Notes [Member]
Debt Instrument, Share Price (in dollars per share) | $ / shares	$ 23.8
The 2027 Notes [Member] | Fair Value, Inputs, Level 1 [Member]
Debt Instrument, Fair Value Disclosure	$ 54,700
Asset-backed Notes 2022 [Member] | Fair Value, Inputs, Level 3 [Member]
Debt Instrument, Fair Value Disclosure	$ 100,000
Measurement Input, Hypothetical Market Yields [Member]
Debt Instrument, Measurement Input			0.25

Note 6 - Fair Value - Assets at

Note 6 - Fair Value - Assets at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Recurring [Member]
Investments, fair value	$ 711,116	$ 709,085
Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	670,773	670,172
Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	23,928	24,594
Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	9,192	6,430
Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	7,223	7,889
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]
Investments, fair value	398	608
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	398	608
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]
Investments, fair value	772	1,619
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	772	1,619
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 3 [Member]
Investments, fair value	709,946	706,858
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]
Investments, fair value	709,946	706,858
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	670,773	670,172
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	23,156	22,975
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	9,192	6,430
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	$ 6,825	$ 7,281

Note 6 - Fair Value - Significa

Note 6 - Fair Value - Significant Level 3 Fair Value Measurement Inputs (Details) - Fair Value, Inputs, Level 3 [Member] $ in Thousands		Mar. 31, 2024 USD ($)		Dec. 31, 2023 USD ($)
Investments, fair value		$ 709,946		$ 706,858
Multiple Probability Weighted Cash Flow Model [Member] | Minimum [Member] | Probability Weighting [Member]
Investments, measurement input		0
Multiple Probability Weighted Cash Flow Model [Member] | Maximum [Member] | Probability Weighting [Member]
Investments, measurement input		0.20
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member]
Investments, fair value		$ 619,773		$ 617,529
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member] | Minimum [Member] | Hypothetical Market Yield [Member]
Investments, measurement input		0.11		11
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member] | Maximum [Member] | Hypothetical Market Yield [Member]
Investments, measurement input		0.20		24
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member] | Weighted Average [Member] | Hypothetical Market Yield [Member]
Investments, measurement input	[1]	0.15		15
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member]
Investments, fair value		$ 51,000		$ 52,643
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Minimum [Member] | Probability Weighting [Member]
Investments, measurement input		0.05		20
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Maximum [Member] | Probability Weighting [Member]
Investments, measurement input		0.95		100
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Weighted Average [Member] | Probability Weighting [Member]
Investments, measurement input	[1]	0.44		50
Warrant [Member] | Black-scholes Valuation Model [Member]
Investments, fair value		$ 23,094		$ 22,913
Warrant [Member] | Black-scholes Valuation Model [Member] | Measurement Input, Price Volatility [Member]
Investments, measurement input		0.25		25
Warrant [Member] | Black-scholes Valuation Model [Member] | Expected Proceeds [Member]
Investments, fair value				$ 62
Warrant [Member] | Black-scholes Valuation Model [Member] | Minimum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		0		0
Warrant [Member] | Black-scholes Valuation Model [Member] | Minimum [Member] | Measurement Input, Discount for Lack of Marketability [Member]
Investments, measurement input		0.18	[1]	0
Warrant [Member] | Black-scholes Valuation Model [Member] | Minimum [Member] | Estimated Time to Exit [Member]
Investments, measurement input		1		1
Warrant [Member] | Black-scholes Valuation Model [Member] | Maximum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		1,898.58		1,899
Warrant [Member] | Black-scholes Valuation Model [Member] | Maximum [Member] | Measurement Input, Discount for Lack of Marketability [Member]
Investments, measurement input				20
Warrant [Member] | Black-scholes Valuation Model [Member] | Maximum [Member] | Estimated Time to Exit [Member]
Investments, measurement input		5		5
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Measurement Input, Share Price [Member]
Investments, measurement input	[1]	61.04		64.95
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Measurement Input, Price Volatility [Member]
Investments, measurement input	[1]	0.25		25
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Measurement Input, Discount for Lack of Marketability [Member]
Investments, measurement input	[1]			18
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Estimated Time to Exit [Member]
Investments, measurement input	[1]	3		3
Warrant [Member] | Expected Proceeds [Member]
Investments, fair value		$ 62
Warrant [Member] | Expected Proceeds [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		0.25		0.25
Warrant [Member] | Expected Proceeds [Member] | Weighted Average [Member] | Measurement Input, Share Price [Member]
Investments, measurement input	[1]	0.25		0.25
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member]
Investments, fair value		$ 9,192		$ 6,430
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Measurement Input, Discount Rate [Member]
Investments, measurement input		0.25		25
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Minimum [Member] | Probability Weighting [Member]
Investments, measurement input		0.30		30
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Maximum [Member] | Probability Weighting [Member]
Investments, measurement input		1		100
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Weighted Average [Member] | Probability Weighting [Member]
Investments, measurement input	[1]	0.75		81
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Weighted Average [Member] | Measurement Input, Discount Rate [Member]
Investments, measurement input	[1]	0.25		25
Equity Securities [Member] | Last Equity Financing [Member]
Investments, fair value		$ 6,825		$ 7,281
Equity Securities [Member] | Last Equity Financing [Member] | Minimum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		0		0.56
Equity Securities [Member] | Last Equity Financing [Member] | Maximum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		215.03		215.03
Equity Securities [Member] | Last Equity Financing [Member] | Weighted Average [Member] | Measurement Input, Share Price [Member]
Investments, measurement input	[1]	18.21		17.15
[1]Weighted average is calculated by multiplying (a) the unobservable input for each investment in the investment type by (b) (1) the fair value of the related investment in the investment type divided by (2) the total fair value of the investment type.

Note 6 - Fair Value - Reconcili

Note 6 - Fair Value - Reconciliation of Level 3 Assets Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Balance	$ 706,858	$ 716,319
Purchase of investments	23,319	47,008
Warrants received and classified as Level 3	128	141
Principal payments received on investments	(19,643)	(39,756)
Payment-in-kind interest on investments	1,382	1,204
Proceeds from sale of investments	(41)	(6,520)
Net realized gain (loss) on investments	21	(134)
Unrealized (depreciation) appreciation included in earnings	(2,903)	(5,867)
Transfer out of debt investments	0	0
Other	825	1,012
Balance	709,946	713,407
Debt [Member]
Balance	670,172	686,458
Purchase of investments	22,177	46,998
Warrants received and classified as Level 3	0	0
Principal payments received on investments	(19,080)	(39,756)
Payment-in-kind interest on investments	1,382	1,204
Proceeds from sale of investments	(41)	(6,508)
Net realized gain (loss) on investments	38	7
Unrealized (depreciation) appreciation included in earnings	(1,509)	(4,566)
Transfer out of debt investments	(3,191)	(295)
Other	825	1,012
Balance	670,773	684,554
Warrant [Member]
Balance	22,975	26,145
Purchase of investments	0	0
Warrants received and classified as Level 3	128	141
Principal payments received on investments	0	0
Payment-in-kind interest on investments	0	0
Proceeds from sale of investments	0	(12)
Net realized gain (loss) on investments	(17)	(141)
Unrealized (depreciation) appreciation included in earnings	70	(1,490)
Transfer out of debt investments	0	(5)
Other	0	0
Balance	23,156	24,638
Equity Securities [Member]
Balance	7,281	2,416
Purchase of investments	750	10
Warrants received and classified as Level 3	0	0
Principal payments received on investments	0	0
Payment-in-kind interest on investments	0	0
Proceeds from sale of investments	0	0
Net realized gain (loss) on investments	0	0
Unrealized (depreciation) appreciation included in earnings	(1,206)	189
Transfer out of debt investments	0	300
Other	0	0
Balance	6,825	2,915
Other Investments [Member]
Balance	6,430	1,300
Purchase of investments	392	0
Warrants received and classified as Level 3	0	0
Principal payments received on investments	(563)	0
Payment-in-kind interest on investments	0	0
Proceeds from sale of investments	0	0
Net realized gain (loss) on investments	0	0
Unrealized (depreciation) appreciation included in earnings	(258)	0
Transfer out of debt investments	3,191	0
Other	0	0
Balance	$ 9,192	$ 1,300

Note 7 - Borrowings (Details Te

Note 7 - Borrowings (Details Textual) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended		12 Months Ended
	May 24, 2023	Feb. 25, 2022	Apr. 21, 2020	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Jun. 29, 2023	Nov. 09, 2022	Jun. 15, 2022	Mar. 30, 2021	Aug. 13, 2019
Restricted Investments				$ 2,533		$ 2,642
Long-Term Debt, Gross				456,000		466,000
Debt Instrument, Face Amount				$ 615,000		615,000
Key Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity, Accordian Feature							$ 150,000
Line of Credit Facility, Maximum Borrowing Capacity							$ 300,000
Line of Credit Facility, Advance Rate of Eligible Debt Investments							60%
Long-Term Debt, Weighted Average Interest Rate, over Time				8.75%	7.94%
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage				0.50%
Line of Credit Facility, Current Borrowing Capacity				$ 90,000		80,000
Line of Credit Facility, Remaining Borrowing Capacity				20,300		25,000
Long-Term Debt, Gross				60,000		70,000
Debt Instrument, Face Amount				$ 150,000		$ 150,000
Key Facility [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate						0.25%
Debt Instrument, Variable Rate				8.50%		8.50%
NYL Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 250,000		$ 100,000
Line of Credit Facility, Current Borrowing Capacity				$ 69,000		$ 69,000
Line of Credit Facility, Remaining Borrowing Capacity				900		17,400
Line of Credit Facility, Maximum Borrowing Capacity, Accordion Feature			$ 200,000
Line of Credit Facility, Advance Rate			67%
Line of Credit Facility, Change in Maximum Borrowing Capacity	$ 50,000	$ 100,000
Debt Instrument, Interest Rate, Stated Percentage	4.60%
Long-Term Line of Credit				$ 181,000		181,000
Line of Credit Facility, Interest Rate at Period End				6.18%	5.57%
Restricted Investments				$ 1,400		1,400
Long-Term Debt, Gross				181,000		181,000
Debt Instrument, Face Amount				250,000		250,000
NYL Facility [Member] | USD Mid-market Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		3%
NYL Facility [Member] | Three Year I Curve [Member]
Debt Instrument, Basis Spread on Variable Rate	3.50%
Asset-backed Notes 2019 [Member]
Debt Instrument, Interest Rate, Stated Percentage											4.21%
Debt Instrument, Face Amount											$ 160,000
Asset-backed Notes 2022 [Member]
Debt Instrument, Interest Rate, Stated Percentage								7.56%
Restricted Investments				1,300		1,200
Long-Term Debt, Gross				100,000		100,000
Debt Instrument, Face Amount				100,000		100,000		$ 157,800
The 2026 Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage										4.875%
Long-Term Debt, Gross				57,500		57,500
Debt Instrument, Face Amount				57,500		57,500				$ 57,500
The 2026 Notes Underwriter Option [Member]
Debt Instrument, Face Amount										$ 7,500
Debt Instrument, Convertible, Conversion Price (in dollars per share)										$ 25
The 2027 Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage									6.25%
Long-Term Debt, Gross				57,500		57,500
Debt Instrument, Face Amount				$ 57,500		$ 57,500			$ 50,000
The 2027 Notes Underwriter Option [Member]
Debt Instrument, Face Amount									$ 7,500
Debt Instrument, Convertible, Conversion Price (in dollars per share)									$ 25
Minimum [Member]
Asset Coverage to Borrowings, Ratio, Percent				150%
Minimum [Member] | Key Facility [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate						4.25%
Minimum [Member] | NYL Facility [Member] | USD Mid-market Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate			3.55%
Maximum [Member]
Asset Coverage to Borrowings, Ratio, Percent				173%
Maximum [Member] | NYL Facility [Member] | USD Mid-market Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate			5.15%

Note 7 - Borrowings - Borrowing

Note 7 - Borrowings - Borrowings (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Nov. 09, 2022	Jun. 15, 2022	Mar. 30, 2021
Total commitment	$ 615,000	$ 615,000
Balance outstanding	456,000	466,000
Unused commitment	159,000	149,000
Unamortized debt issuance costs attributable to term borrowings	(3,510)	(3,765)
Total borrowings outstanding, net	452,490	462,235
Key Facility [Member]
Total commitment	150,000	150,000
Balance outstanding	60,000	70,000
Unused commitment	90,000	80,000
NYL Facility [Member]
Total commitment	250,000	250,000
Balance outstanding	181,000	181,000
Unused commitment	69,000	69,000
Asset-backed Notes 2022 [Member]
Total commitment	100,000	100,000	$ 157,800
Balance outstanding	100,000	100,000
Unused commitment	0	0
The 2027 Notes [Member]
Total commitment	57,500	57,500		$ 50,000
Balance outstanding	57,500	57,500
Unused commitment	0	0
The 2026 Notes [Member]
Total commitment	57,500	57,500			$ 57,500
Balance outstanding	57,500	57,500
Unused commitment	$ 0	$ 0

Note 8 - Financial Instrument_3

Note 8 - Financial Instruments With Off-balance-sheet Risk (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Fair Value Disclosure, off-Balance-Sheet Risks, Amount, Liability	$ 1,787	$ 2,033
Commitments to Extend Credit [Member]
Other Commitment	168,200	180,500
Unfunded Loan Commitment [Member]
Fair Value Disclosure, off-Balance-Sheet Risks, Amount, Liability	$ 1,800	$ 2,000

Note 8 - Financial Instrument_4

Note 8 - Financial Instruments With Off-balance-sheet Risk - Unfunded Commitments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Unfunded commitments, principal balance	$ 168,236	$ 180,500
Fair value of unfunded commitment liability	1,787	2,033
BrightInsight, Inc. [Member]
Unfunded commitments, principal balance	15,500	15,500
Fair value of unfunded commitment liability	205	241
Britecore Holdings, Inc. [Member]
Unfunded commitments, principal balance	2,500	5,000
Fair value of unfunded commitment liability	36	72
Candesant Biomedical Corporation [Member]
Unfunded commitments, principal balance	10,000	10,000
Fair value of unfunded commitment liability	151	151
Ceribell, Inc. [Member]
Unfunded commitments, principal balance	21,000	0
Fair value of unfunded commitment liability	120	0
Divergent Technologies, Inc. [Member]
Unfunded commitments, principal balance	0	11,250
Fair value of unfunded commitment liability	0	118
Elligo Healthcare Research, Inc. [Member]
Unfunded commitments, principal balance	15,000	15,000
Fair value of unfunded commitment liability	194	194
MicroTransponder, Inc. [Member]
Unfunded commitments, principal balance	22,500	22,500
Fair value of unfunded commitment liability	0	0
Mirantis, Inc [Member]
Unfunded commitments, principal balance	15,000	15,000
Fair value of unfunded commitment liability	136	136
Nexii Building Solutions, Inc [Member]
Unfunded commitments, principal balance	486	0
Fair value of unfunded commitment liability	0	0
Optoro, Inc. [Member]
Unfunded commitments, principal balance	6,250	6,250
Fair value of unfunded commitment liability	0	0
Parse Biosciences, Inc. [Member]
Unfunded commitments, principal balance	15,000	15,000
Fair value of unfunded commitment liability	251	251
SafelyYou, Inc [Member]
Unfunded commitments, principal balance	20,000	20,000
Fair value of unfunded commitment liability	270	270
Sonex Health, Inc. [Member]
Unfunded commitments, principal balance	0	15,000
Fair value of unfunded commitment liability	0	176
Supply Network Visibility Holdings, LLC [Member]
Unfunded commitments, principal balance	10,000	10,000
Fair value of unfunded commitment liability	35	35
Tallac Therapeutics, Inc [Member]
Unfunded commitments, principal balance	5,000	10,000
Fair value of unfunded commitment liability	229	229
Viken Detection Corporation [Member]
Unfunded commitments, principal balance	10,000	10,000
Fair value of unfunded commitment liability	$ 160	$ 160

Note 9 - Concentrations of Cr_2

Note 9 - Concentrations of Credit Risk (Details Textual) - Debt Investments [Member]	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Investment Concentration Risk [Member] | Reported Value Measurement [Member]
Concentration Risk, Percentage	23%		23%
Investment Concentration Risk [Member] | Estimate of Fair Value Measurement [Member]
Concentration Risk, Percentage	23%		22%
Interest Income [Member] | Reported Value Measurement [Member]
Concentration Risk, Percentage	16%	22%
Interest Income [Member] | Estimate of Fair Value Measurement [Member]
Concentration Risk, Percentage	21%	22%

Note 10 - Distributions (Detail

Note 10 - Distributions (Details Textual) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Common Stock, Dividends, Per Share, Cash Paid (in dollars per share)	$ 0.33
Earnings Per Share, Basic (in dollars per share)	0.38	$ 0.46
Earnings Per Share, Basic, Undistributed (in dollars per share)	$ 1.3

Note 10 - Distributions - Distr

Note 10 - Distributions - Distribution Activity (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended	12 Months Ended	24 Months Ended
	Apr. 26, 2024	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2023
Distributions declared per share (in dollars per share)		$ 0.38	$ 0.33			$ 1.37
Dividends, cash		$ 5,199				$ 41,881
Dividends, shares (in shares)		24,315				145,743
Dividends, stock				$ 273		$ 1,833
August 16, 2024 Dividend [Member] | Forecast [Member]
Distributions declared per share (in dollars per share)	$ 0.11
July 17, 2024 Dividend [Member] | Forecast [Member]
Distributions declared per share (in dollars per share)	0.11
First 2/23/2024 Dividend [Member]
Record date		May 17, 2024
Payment date		Jun. 14, 2024
Distributions declared per share (in dollars per share)		$ 0.11
Dividends, cash		$ 0
Dividends, shares (in shares)		0
Dividends, stock		$ 0
June 17, 2024 Dividend [Member] | Forecast [Member]
Distributions declared per share (in dollars per share)	$ 0.11
Second 2/23/2024 Dividend [Member]
Record date		Apr. 18, 2024
Payment date		May 15, 2024
Distributions declared per share (in dollars per share)		$ 0.11
Dividends, cash		$ 0
Dividends, shares (in shares)		0
Dividends, stock		$ 0
Third 2/23/2024 Dividend [Member]
Record date		Mar. 19, 2024
Payment date		Apr. 16, 2024
Distributions declared per share (in dollars per share)		$ 0.05
Dividends, cash		$ 1,625
Dividends, shares (in shares)		7,598
Dividends, stock		$ 85
Fourth 2/23/2024 Dividend [Member]
Record date		Mar. 19, 2024
Payment date		Apr. 16, 2024
Distributions declared per share (in dollars per share)		$ 0.11
Dividends, cash		$ 3,574
Dividends, shares (in shares)		16,717
Dividends, stock		$ 188
First 10/27/2023 Dividend [Member]
Record date					Feb. 16, 2024
Payment date					Mar. 15, 2024
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,463
Dividends, shares (in shares)					18,257
Dividends, stock					$ 210
Second 10/27/2023 Dividend [Member]
Record date					Jan. 18, 2024
Payment date					Feb. 14, 2024
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,462
Dividends, shares (in shares)					15,873
Dividends, stock					$ 210
Third 10/27/2023 Dividend [Member]
Record date					Dec. 19, 2023
Payment date					Jan. 16, 2024
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,472
Dividends, shares (in shares)					14,563
Dividends, stock					$ 199
Fourth 10/27/2023 Dividend [Member]
Record date					Nov. 17, 2023
Payment date					Dec. 15, 2023
Distributions declared per share (in dollars per share)					$ 0.05
Dividends, cash					$ 1,574
Dividends, shares (in shares)					7,137
Dividends, stock					$ 93
First 7/28/2023 Dividend [Member]
Record date				Nov. 17, 2023
Payment date				Dec. 15, 2023
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,463
Dividends, shares (in shares)					15,701
Dividends, stock					$ 206
Second 7/28/2023 Dividend [Member]
Record date				Oct. 18, 2023
Payment date				Nov. 11, 2023
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,493
Dividends, shares (in shares)					14,022
Dividends, stock					$ 173
Third 7/28/2023 Dividend [Member]
Record date				Sep. 19, 2023
Payment date				Oct. 16, 2023
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,445
Dividends, shares (in shares)					15,067
Dividends, stock					$ 184
First 4/28/2023 Dividend [Member]
Record date				Aug. 17, 2023
Payment date				Sep. 15, 2023
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,458
Dividends, shares (in shares)					8,665
Dividends, stock					$ 106
Second 4/28/2023 [Member]
Record date				Jul. 18, 2023
Payment date				Aug. 15, 2023
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,427
Dividends, shares (in shares)					8,307
Dividends, stock					$ 105
Third 4/28/2023 Dividend [Member]
Record date				Jun. 16, 2023
Payment date				Jul. 14, 2023
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,434
Dividends, shares (in shares)					7,424
Dividends, stock					$ 96
First 2/23/2023 Dividend [Member]
Record date				May 18, 2023
Payment date				Jun. 14, 2023
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,087
Dividends, shares (in shares)					7,128
Dividends, stock					$ 86
Second 2/23/2023 Dividend [Member]
Record date				Apr. 18, 2023
Payment date				May 16, 2023
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,068
Dividends, shares (in shares)					6,705
Dividends, stock					$ 84
Third 2/23/2023 Dividend [Member]
Record date				Mar. 17, 2023
Payment date				Apr. 14, 2023
Distributions declared per share (in dollars per share)					$ 0.11
Dividends, cash					$ 3,035
Dividends, shares (in shares)					6,894
Dividends, stock					$ 81

Note 11 - Financial Highlight_2

Note 11 - Financial Highlights - Financial Highlights (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Net asset value at beginning of period (in dollars per share)		$ 9.71	$ 11.47
Net investment income (in dollars per share)		0.38	0.46
Realized loss (in dollars per share)		0	(0.01)
Unrealized (depreciation) appreciation on investments (in dollars per share)		(0.12)	(0.26)
Net increase in net assets resulting from operations (in dollars per share)		0.26	0.19
Distributions declared (in dollars per share)	[1]	(0.38)	(0.33)
From net investment income (in dollars per share)		(0.38)	(0.33)
From net realized gain on investments (in dollars per share)		0	0
Return of capital (in dollars per share)		0	0
Other (in dollars per share)	[2]	0.05	0.01
Net asset value at end of period (in dollars per share)		9.64	11.34
Per share market value, beginning of period (in dollars per share)		13.17	11.6
Per share market value, end of period (in dollars per share)		$ 11.37	$ 11.28
Total return based on a market value	[3]	(11.20%)	0.10%
Shares outstanding at end of period (in shares)		34,469,878	28,377,357	33,367,389
Expenses without incentive fee (4)	[4]	15.70%	14.80%
Incentive fees	[4]	0.40%	3.70%
Net expenses	[4]	16.10%	18.50%
Net investment income with incentive fee (4)	[4]	15.40%	16.30%
Net assets at the end of the period		$ 332,121	$ 321,683	$ 323,981
Average net asset value		$ 328,051	$ 320,066
Average debt per share (in dollars per share)		$ 13.61	$ 15.61
Portfolio turnover ratio	[5]	1.40%	4.20%
[1]Distributions are determined based on taxable income calculated in accordance with income tax regulations, which may differ from amounts determined under GAAP due to (i) changes in unrealized appreciation and depreciation, (ii) temporary and permanent differences in income and expense recognition, and (iii) the amount of spillover income carried over from a given tax year for distribution in the following tax year. The final determination of taxable income for each tax year, as well as the tax attributes for distributions in such tax year, will be made after the close of the tax year.[2]Includes the impact of the different share amounts as a result of calculating per share data based on the weighted average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. The issuance of common stock on a per share basis reflects the incremental net asset value changes as a result of the issuance of common stock in the Company’s continuous public offering and pursuant to the Company’s distribution reinvestment plan. The issuance of common stock at an offering price, net of sales commissions and dealer manager fees, that is greater than the net asset value per share results in an increase in net asset value per share.[3]The total return equals the change in the ending market value over the beginning of period price per share plus distributions paid per share during the period, divided by the beginning price.[4]Annualized.[5]Calculated by dividing the lesser of purchases or the sum of (1) principal prepayments and (2) maturities by the monthly average debt investment balance.

Note 12 - Subsequent Events (De

Note 12 - Subsequent Events (Details Textual) - USD ($) $ in Thousands				1 Months Ended	3 Months Ended
	Apr. 22, 2024	Apr. 11, 2024	Apr. 01, 2024	Apr. 30, 2024	Mar. 31, 2024	Mar. 31, 2023
Proceeds from Issuance of Common Stock					$ 11,972	$ 7,174
Subsequent Event [Member] | Provivi, Inc. [Member] | Debt Securities [Member]
Proceeds from Sale, Maturity and Collection of Investments			$ 4,700
Proceeds from Debt Securities, End-of-term, Amount			$ 300
Subsequent Event [Member] | Better Place Forests Co. [Member]
Payments to Acquire Investments		$ 500
Subsequent Event [Member] | CAMP NYC, Inc [Member] | Debt Securities [Member]
Proceeds from Sale, Maturity and Collection of Investments	$ 1,000
The 2023 Equity Distribution Agreement [Member]
Stock Issued During Period, Shares, New Issues (in shares)					1,053,796
Proceeds from Issuance of Common Stock					$ 12,000
Payments of Stock Issuance Costs					$ 300
The 2023 Equity Distribution Agreement [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues (in shares)				526,581
Proceeds from Issuance of Common Stock				$ 5,800
Payments of Stock Issuance Costs				$ 100